Tom H. Greene, PhD

Chief, Division of Biostatistics

Languages

  • English

Academic Information

  • Departments: Population Health Sciences - Professor
  • Divisions: Biostatistics, Epidemiology, Public Health

Academic Office Information

  • 801-213-3741
  • Williams Building
    Division of Epidemiology
    295 Chipeta Way
    Salt Lake City, UT 84108

Education History

Type School Degree
Doctoral Training Cornell University
Statistics/ Mathematics and Operation Research Minor
Ph.D.
Graduate Training Cornell University
Statistics
M.S.
Undergraduate University of Kentucky
Mathematics and Psychology
B.S.

Selected Publications

Journal Article

  1. Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, Winkelmayer WC, Ellenberg SS, Cifelli D, Madigan R, Young A, Angeletti M, Wingard RL, Kahn C, Nissenson AR, Maddux FW, Abbott KC, Landis JR (2019 May). The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration. J Am Soc Nephrol, 30(5), 890-903.
  2. Greene T, Shmueli G, Ray S, Fell J (2019 Apr 27). Adjusting to the GDPR: The Impact on Data Scientists and Behavioral Researchers.LID - 10.1089/big.2018.0176 [doi]. (Epub ahead of print) Big Data.
  3. Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW (2019 Apr 14). Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.LID - 10.1056/NEJMoa1811744 [doi]. (Epub ahead of print) N Engl J Med.
  4. Wang S, Malebari AM, Greene TF, OBoyle NM, Fayne D, Nathwani SM, Twamley B, McCabe T, Keely NO, Zisterer DM, Meegan MJ (2019 Apr 11). 3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells.LID - E56 [pii]LID - 10.3390/ph12020056 [doi]. Pharmaceuticals (Basel), 12(2).
  5. Clewell HJ 3rd, Gentry PR, Hack CE, Greene T, Clewell RA (2019 Apr). An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking water. Regul Toxicol Pharmacol, 103, 237-252.
  6. McCrary H, Sheng X, Greene T, Park A (2019 Mar). Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir. Int J Pediatr Otorhinolaryngol, 118, 124-127.
  7. Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, Dember LM, Diaz-Linhart Y, Dubovsky A, Greene T, Grote N, Kutner N, Trivedi MH, Quinn DK, Ver Halen N, Weisbord SD, Young BA, Kimmel PL, Hedayati SS (2019 Feb 26). Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.LID - 10.7326/M18-2229 [doi]. (Epub ahead of print) Ann Intern Med.
  8. Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA (2019 Feb). Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol, 7(2), 128-139.
  9. Gelkopf M, Lapid Pickman L, Carlson EB, Greene T (2019 Feb). The Dynamic Relations Among Peritraumatic Posttraumatic Stress Symptoms: An Experience Sampling Study During Wartime. J Trauma Stress, 32(1), 119-129.
  10. Bress AP, Dodson JA, King JB, Sauer BC, Reese T, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, LaFleur J (2018 Dec 1). Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. Am J Cardiol, 122(11), 1809-1816.
  11. Hall IE, Akalin E, Bromberg JS, Doshi MD, Greene T, Harhay MN, Jia Y, Mansour SG, Mohan S, Muthukumar T, Reese PP, Schroppel B, Singh P, Thiessen-Philbrook HR, Weng FL, Parikh CR (2018 Nov 14). Deceased-donor acute kidney injury is not associated with kidney allograft failure.LID - S0085-2538(18)30715-4 [pii]LID - 10.1016/j.kint.2018.08.047 [doi]. (Epub ahead of print) Kidney Int.
  12. Frodsham SG, Yu Z, Lyons AM, Agarwal A, Pezzolesi MH, Dong L, Srinivas TR, Ying J, Greene T, Raphael KL, Smith KR, Pezzolesi MG (2018 Nov 13). The Familiality of Rapid Renal Decline in Diabetes.LID - db180838 [pii]LID - 10.2337/db18-0838 [doi]. (Epub ahead of print) Diabetes.
  13. Robbin ML, Greene T, Allon M, Dember LM, Imrey PB, Cheung AK, Himmelfarb J, Huber TS, Kaufman JS, Radeva MK, Roy-Chaudhury P, Shiu YT, Vazquez MA, Umphrey HR, Alexander L, Abts C, Beck GJ, Kusek JW, Feldman HI (2018 Nov). Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study. J Am Soc Nephrol, 29(11), 2735-2744.
  14. Greene T, Hartnett ME (2018 Oct 25). Programming Error Led to Underestimate of Effect Sizes in Study of Association of Maternal Preeclampsia and Risk of Infant Retinopathy of Prematurity.LID - 10.1001/jamaophthalmol.2018.5055 [doi]. (Epub ahead of print) JAMA Ophthalmol.
  15. Lane E, Fritz JM, Greene T, Maddox D (2018 Oct 25). The effectiveness of training physical therapists in pain neuroscience education on patient reported outcomes for patients with chronic spinal pain: a study protocol for a cluster randomized controlled trial. BMC Musculoskelet Disord, 19(1), 386.
  16. Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, Cutler J, Fine L, Boucher R, Wei G, Zhang C, Kramer H, Bress AP, Kimmel PL, Oparil S, Lewis CE, Rahman M, Cushman WC (2018 Sep 18). Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT. J Am Heart Assoc, 7(18), e009326.
  17. Zuk A, Palevsky PM, Fried L, Harrell FE Jr, Khan S, McKay DB, Devey L, Chawla L, de Caestecker M, Kaufman JS, Thompson BT, Agarwal A, Greene T, Okusa MD, Bonventre JV, Dember LM, Liu KD, Humphreys BD, Gossett D, Xie Y, Norton JM, Kimmel PL, Star RA (). Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop. Clin J Am Soc Nephrol, 13(7), 1113-1123.
  18. Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Stoddard G, Ix JH, Chonchol M, Kramer H, Cheung AK, Kimmel PL, Whelton PK, Chertow GM (2018 Jul). Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. Lancet Diabetes Endocrinol, 6(7), 555-563.
  19. Jones BE, Haroldsen C, Madaras-Kelly K, Goetz MB, Ying J, Sauer B, Jones MM, Leecaster M, Greene T, Fridkin SK, Neuhauser MM, Samore MH (2018 Jul). In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia. Med Care, 56(7), 626-633.
  20. Fritz JM, Sharpe JA, Lane E, Santillo D, Greene T, Kawchuk G (2018 Jun 4). Optimizing treatment protocols for spinal manipulative therapy: study protocol for a randomized trial. Trials, 19(1), 306.
  21. Murtaugh MA, Beasley JM, Appel LJ, Guenther PM, McFadden M, Greene T, Tooze JA (2018 May). Relationship of Sodium Intake and Blood Pressure Varies With Energy Intake: Secondary Analysis of the DASH (Dietary Approaches to Stop Hypertension)-Sodium Trial. Hypertension, 71(5), 858-865.
  22. Allon M, Imrey PB, Cheung AK, Radeva M, Alpers CE, Beck GJ, Dember LM, Farber A, Greene T, Himmelfarb J, Huber TS, Kaufman JS, Kusek JW, Roy-Chaudhury P, Robbin ML, Vazquez MA, Feldman HI (2018 May). Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study. Am J Kidney Dis, 71(5), 677-689.
  23. Coresh J, Inker LA, Sang Y, Chen J, Shafi T, Post WS, Shlipak MG, Ford L, Goodman K, Perichon R, Greene T, Levey AS (2018 Apr 30). Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study.LID - 10.1093/ndt/gfy094 [doi]. (Epub ahead of print) Nephrol Dial Transplant.
  24. Kramer H, Boucher RE, Leehey D, Fried L, Wei G, Greene T, Rosas SE, Cooper R, Cao G, Beddhu S (2018 Apr). Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria. Diabetes Care, 41(4), 775-781.
  25. Bennett TD, Greene TH, Keenan HT (2018 Apr 1). Functional Outcome After Intracranial Presuure Monitoring-Reply. JAMA Pediatr, 172(4), 393.
  26. Stenehjem E, Hersh AL, Buckel WR, Jones P, Sheng X, Evans RS, Burke JP, Lopansri BK, Srivastava R, Greene T, Pavia AT (2018 Feb 23). Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention.LID - 10.1093/cid/ciy155 [doi]. (Epub ahead of print) Clin Infect Dis.
  27. Bowen RC, Zhou AX, Bondalapati S, Lawyer TW, Snow KB, Evans PR, Bardsley T, McFarland M, Kliethermes M, Shi D, Mamalis CA, Greene T, Rudnisky CJ, Ambati BK (2018 Jan 11). Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.LID - bjophthalmol-2017-311051 [pii]LID - 10.1136/bjophthalmol-2017-311051 [doi]. (Epub ahead of print) Br J Ophthalmol.
  28. Mao H, Li L, Greene T (2018 Jan 1). Propensity score weighting analysis and treatment effect discovery. Stat Methods Med Res, 962280218781171.
  29. Weldegiorgis M, de Zeeuw D, Li L, Parving HH, Hou FF, Remuzzi G, Greene T, Heerspink HJL (2018 Jan). Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. Am J Kidney Dis, 71(1), 91-101.
  30. Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Xie J, Zhang H, Zinman B, Desai M, Perkovic V (2017 Dec 13). The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics. Am J Nephrol, 46(6), 462-472.
  31. Brown SM, Wilson EL, Presson AP, Dinglas VD, Greene T, Hopkins RO, Needham DM (2017 Dec). Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes. Thorax, 72(12), 1094-1103.
  32. Khader K, Thomas A, Huskins WC, Leecaster M, Zhang Y, Greene T, Redd A, Samore MH (2017 Winter). A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies. Open Forum Infect Dis, 4(1), ofw247.
  33. Li L, Luo S, Hu B, Greene T (2017 Dec). Dynamic Prediction of Renal Failure Using Longitudinal Biomarkers in a Cohort Study of Chronic Kidney Disease. Stat Biosci, 9(2), 357-378.
  34. Stephens-Shields AJ, Spieker AJ, Anderson A, Drawz P, Fischer M, Sozio SM, Feldman H, Joffe M, Yang W, Greene T (2017 Nov 20). Blood pressure and the risk of chronic kidney disease progression using multistate marginal structural models in the CRIC Study. Stat Med, 36(26), 4167-4181.
  35. Raphael KL, Gilligan S, Hostetter TH, Greene T, Beddhu S (2017 Nov 16). Association between Urine Ammonium and Urine TGF-beta1 in CKD.LID - CJN.07510717 [pii]LID - 10.2215/CJN.07510717 [doi]. (Epub ahead of print) Clin J Am Soc Nephrol.
  36. Thomas A, Khader K, Redd A, Leecaster M, Zhang Y, Jones M, Greene T, Samore M (2017 Oct 12). Extended models for nosocomial infection: parameter estimation and model selection.LID - 10.1093/imammb/dqx010 [doi]. (Epub ahead of print) Math Med Biol.
  37. Beddhu S, Chertow GM, Cheung AK, Cushman WC, Rahman M, Greene T, Wei G, Campbell RC, Conroy M, Freedman BI, Haley WE, Horwitz EJ, Kitzman DW, Lash J, Papademetriou V, Pisoni R, Riessen E, Rosendorff C, Watnick SG, Whittle J, Whelton PK (2017 Oct 11). Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared to Standard Blood Pressure Control.LID - CIRCULATIONAHA.117.030848 [pii]LID - 10.1161/CIRCULATIONAHA.117.030848 [doi]. (Epub ahead of print) Circulation.
  38. Cheung AK, Imrey PB, Alpers CE, Robbin ML, Radeva M, Larive B, Shiu YT, Allon M, Dember LM, Greene T, Himmelfarb J, Roy-Chaudhury P, Terry CM, Vazquez MA, Kusek JW, Feldman HI (2017 Oct). Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study. J Am Soc Nephrol, 28(10), 3005-3013.
  39. Bennett TD, DeWitt PE, Greene TH, Srivastava R, Riva-Cambrin J, Nance ML, Bratton SL, Runyan DK, Dean JM, Keenan HT (2017 Oct 1). Functional Outcome After Intracranial Pressure Monitoring for Children With Severe Traumatic Brain Injury. JAMA Pediatr, 171(10), 965-971.
  40. Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK (2017 Sep 19). Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Ann Intern Med, 167(6), 375-383.
  41. Hung M, Saltzman CL, Greene T, Voss MW, Bounsanga J, Gu Y, Anderson MB, Peters CL, Gililland J, Pelt CE (2017 Sep 16). Evaluating instrument responsiveness in joint function: The HOOS JR, the KOOS JR, and the PROMIS PF CAT.LID - 10.1002/jor.23739 [doi]. (Epub ahead of print) J Orthop Res.
  42. Beddhu S, Wei G, Chen X, Boucher R, Kiani R, Raj D, Chonchol M, Greene T, Murtaugh MA (2017 Sep). Associations of Dietary Protein and Energy Intakes With Protein-Energy Wasting Syndrome in Hemodialysis Patients. Kidney Int Rep, 2(5), 821-830.
  43. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J (2017 Sep). Effects of Intensive BP Control in CKD. J Am Soc Nephrol, 28(9), 2812-2823.
  44. Shulman JP, Weng C, Wilkes J, Greene T, Hartnett ME (2017 Sep 1). Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity. JAMA Ophthalmol, 135(9), 947-953.
  45. Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, Zhang Y, Doumas M, Nord J, Sweeney ME, Taylor AA, Herring C, Kostis WJ, Powell J, Rastogi A, Roumie CL, Wiggers A, Williams JS, Yunis R, Zias A, Evans GW, Greene T, Rocco MV, Cushman WC, Reboussin DM, Feinglos MN, Papademetriou V (2017 Aug 9). Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial.LID - dc170885 [pii]LID - 10.2337/dc17-0885 [doi]. (Epub ahead of print) Diabetes Care.
  46. Jones BE, Brown KA, Jones MM, Huttner BD, Greene T, Sauer BC, Madaras-Kelly K, Rubin MA, Bidwell Goetz M, Samore MH (2017 Aug). Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers. Infect Control Hosp Epidemiol, 38(8), 937-944.
  47. Beddhu S, Chen X, Wei G, Raj D, Raphael KL, Boucher R, Chonchol MB, Murtaugh MA, Greene T (2017 May). Associations of Protein-Energy Wasting Syndrome Criteria With Body Composition and Mortality in the General and Moderate Chronic Kidney Disease Populations in the United States. Kidney Int Rep, 2(3), 390-399.
  48. Raphael KL, Carroll DJ, Murray J, Greene T, Beddhu S (2017 Apr 06). Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease.LID - ASN.2016101151 [pii]LID - 10.1681/ASN.2016101151 [doi]. (Epub ahead of print) J Am Soc Nephrol.
  49. Stevens VW, Nelson RE, Schwab-Daugherty EM, Khader K, Jones MM, Brown KA, Greene T, Croft LD, Neuhauser M, Glassman P, Goetz MB, Samore MH, Rubin MA (2017 Apr 01). Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection. JAMA Intern Med, 177(4), 546-553.
  50. Brown SM, Wilson E, Presson AP, Zhang C, Dinglas VD, Greene T, Hopkins RO, Needham DM (2017 Apr). Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome. Thorax, 72(4), 311-317.
  51. Jalal D, McFadden M, Dwyer JP, Umanath K, Aguilar E, Yagil Y, Greco B, Sika M, Lewis JB, Greene T, Goral S (2017 Apr). Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis. Hemodial Int, 21(2), 243-249.
  52. Brooke BS, Sarfati MR, Zhang Y, Zhang Y, Presson AP, Greene TH, Kraiss LW (2017 Mar 10). Cardiac Stress Testing during Workup for Abdominal Aortic Aneurysm Repair Is Not Associated with Improved Patient Outcomes.LID - S0890-5096(17)30372-2 [pii]LID - 10.1016/j.avsg.2016.10.057 [doi]. (Epub ahead of print) Ann Vasc Surg.
  53. Henriques V, Greene T, Sharma R (2017 Mar). What is causing this patient's periumbilical pain and erythema? JAAPA, 30(3), 49-51.
  54. Voelker J, Berg PH, Sheetz M, Duffin K, Shen T, Moser B, Greene T, Blumenthal SS, Rychlik I, Yagil Y, Zaoui P, Lewis JB (2017 Mar). Anti-TGF-beta1 Antibody Therapy in Patients with Diabetic Nephropathy. J Am Soc Nephrol, 28(3), 953-962.
  55. Magel J, Fritz JM, Greene T, Kjaer P, Marcus RL, Brennan GP (2017 Mar 01). Outcomes of Patients With Acute Low Back Pain Stratified by the STarT Back Screening Tool: Secondary Analysis of a Randomized Trial. Phys Ther, 97(3), 330-337.
  56. Garg AX, Suri RS, Eggers P, Finkelstein FO, Greene T, Kimmel PL, Kliger AS, Larive B, Lindsay RM, Pierratos A, Unruh M, Chertow GM (2017 Mar). Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Kidney Int, 91(3), 746-754.
  57. Umanath K, Greco B, Jalal DI, McFadden M, Sika M, Koury MJ, Niecestro R, Hunsicker LG, Greene T, Lewis JB, Dwyer JP (2017 Mar). The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysis. Clin Nephrol, 87 (2017)(3), 124-133.
  58. Hung M, Saltzman CL, Greene T, Voss MW, Bounsanga J, Gu Y, Wang AA, Hutchinson D, Tyser AR (2017). The responsiveness of the PROMIS instruments and the qDASH in an upper extremity population. Journal of Patient-Reported Outcomes, 1(1), 12.
  59. Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS (2016 Dec). Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD. Am J Kidney Dis, 68(6), 892-900.
  60. Allon M, Greene T, Dember LM, Vita JA, Cheung AK, Hamburg NM, Imrey PB, Kaufman JS, Robbin ML, Shiu YT, Terry CM, Umphrey HR, Feldman HI (2016 Dec). Association between Preoperative Vascular Function and Postoperative Arteriovenous Fistula Development. J Am Soc Nephrol, 27(12), 3788-3795.
  61. Li L, Greene T, Hu B (2016 Nov 27). A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data.LID - 0962280216680239 [pii]. (Epub ahead of print) Stat Methods Med Res.
  62. Stenehjem E, Hersh AL, Sheng X, Jones P, Buckel WR, Lloyd JF, Howe S, Evans RS, Greene T, Pavia AT (2016 Nov 15). Antibiotic Use in Small Community Hospitals. Clin Infect Dis, 63(10), 1273-1280.
  63. Johnson MD, Nkoy FL, Sheng X, Greene T, Stone BL, Garvin J (2016 Nov 10). Direct concurrent comparison of multiple pediatric acute asthma scoring instruments. J Asthma, 1-13.
  64. Lee VS, Kawamoto K, Hess R, Park C, Young J, Hunter C, Johnson S, Gulbransen S, Pelt CE, Horton DJ, Graves KK, Greene TH, Anzai Y, Pendleton RC (). Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality. J Am Med Assoc, 316(10), 1061-72.
  65. Lee VS, Kawamoto K, Hess R, Park C, Young J, Hunter C, Johnson S, Gulbransen S, Pelt CE, Horton DJ, Graves KK, Greene TH, Anzai Y, Pendleton RC (2016 Sep 13). Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality. JAMA, 316(10), 1061-72.
  66. Li G, Greene TC, Nishino TK, Willis CE (2016 Sep 08). Evaluation of cassette-based digital radiography detectors using standardized image quality metrics: AAPM TG-150 Draft Image Detector Tests. J Appl Clin Med Phys, 17(5), 6008.
  67. Inker LA, Mondal H, Greene T, Masaschi T, Locatelli F, Schena FP, Katafuchi R, Appel GB, Maes BD, Li PK, Praga M, Del Vecchio L, Andrulli S, Manno C, Gutierrez E, Mercer A, Carroll KJ, Schmid CH, Levey AS (2016 Sep). Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis. Am J Kidney Dis, 68(3), 392-401.
  68. Hu B, Li L, Greene T (2016 Jul 30). Joint multiple imputation for longitudinal outcomes and clinical events that truncate longitudinal follow-up. Stat Med, 35(17), 2991-3006.
  69. Hu, B, Li, L, amp Greene, T (). Joint multiple imputation for longitudinal outcomes and clinical events that truncate longitudinal follow-up. Stat Med.
  70. Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T (2016 Jun). Long-Term Effects of Frequent In-Center Hemodialysis. J Am Soc Nephrol, 27(6), 1830-6.
  71. Ostrander B, Bardsley T, Korgenski EK, Greene T, Bonkowsky JL (2016 Jun). Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants. Pediatr Neurol, 59, 41-6.
  72. Tin A, Grams ME, Estrella M, Lipkowitz M, Greene TH, Kao WH, Li L, Appel LJ (2016 May 26). Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.LID - CJN.12221115 [pii]. (Epub ahead of print) Clin J Am Soc Nephrol.
  73. Robbin ML, Greene T, Cheung AK, Allon M, Berceli SA, Kaufman JS, Allen M, Imrey PB, Radeva MK, Shiu YT, Umphrey HR, Young CJ (2016 May). Arteriovenous Fistula Development in the First 6 Weeks after Creation. Radiology, 279(2), 620-9.
  74. Brown KA, Daneman N, Stevens VW, Zhang Y, Greene TH, Samore MH, Arora P (2016 Apr). Integrating Time-Varying and Ecological Exposures into Multivariate Analyses of Hospital-Acquired Infection Risk Factors: A Review and Demonstration. Infect Control Hosp Epidemiol, 37(4), 411-9.
  75. Hedayati SS, Daniel DM, Cohen S, Comstock B, Cukor D, Diaz-Linhart Y, Dember LM, Dubovsky A, Greene T, Grote N, Heagerty P, Katon W, Kimmel PL, Kutner N, Linke L, Quinn D, Rue T, Trivedi MH, Unruh M, Weisbord S, Young BA, Mehrotra R (2016 Mar). Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND). Contemp Clin Trials, 47, 1-11.
  76. Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, Boucher R, Greene T, Beddhu S (2016 Mar). The Associations of Plant Protein Intake With All-Cause Mortality in CKD. Am J Kidney Dis, 67(3), 423-30.
  77. Grams ME, Sang Y, Coresh J, Ballew SH, Matsushita K, Levey AS, Greene TH, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP (2016 Feb 8). Candidate Surrogate End Points for ESRD after AKI.LID - ASN.2015070829 [pii]. (Epub ahead of print) J Am Soc Nephrol.
  78. Levin Y, Greene T, Solomon Z (2016 Feb). PTSD symptoms and marital adjustment among ex-POWs' wives. J Fam Psychol, 30(1), 72-81.
  79. Chonchol M, Greene T, Zhang Y, Hoofnagle AN, Cheung AK (2016 Jan). Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study. J Am Soc Nephrol, 27(1), 227-37.
  80. Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW (2016). The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purif, 41(4), 277-86.
  81. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS (2016 Jan). GFR Estimation Using beta-Trace Protein and beta2-Microglobulin in CKD. Am J Kidney Dis, 67(1), 40-8.
  82. Beddhu S, Filipowicz R, Wang B, Wei G, Chen X, Roy AC, DuVall SL, Farrukh H, Habib AN, Bjordahl T, Simmons DL, Munger M, Stoddard G, Kohan DE, Greene T, Huang Y (2016). A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy. Can J Kidney Health Dis, 3, 2054358116675343.
  83. Zaghi D, Weir C, Ying J, Carlin C, Greene T, DeShazo R, Callis Duffin K, Krueger GG (2016). Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients. J Dermatolog Treat, 27(1), 27-30.
  84. Miller K, Frech T, Greene T, Ma KN, McFadden M, Tom-Orme L, Slattery ML, Murtaugh MA (2016). Bone Mineral Density in Navajo Men and Women and Comparison to Non-Hispanic Whites from NHANES (2005-2008). J Health Care Poor Underserved, 27(2), 644-62.
  85. Jones, BE, Sauer, B, Jones, MM, Campo, J, Damal, K, He, T, Ying, J, Greene, T, Goetz, MB, Neuhauser, MM and Hicks, LA (). Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study. Ann Intern Med, 163(2), 73-80.
  86. Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL (2015 Dec). Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema. Hospital Pediatrics, 5(12), 605-12.
  87. Yan G, Cheung AK, Greene T, Yu AJ, Oliver MN, Yu W, Ma JZ, Norris KC (2015 Nov 06). Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics. Clin J Am Soc Nephrol, 10(11), 1979-88.
  88. Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, Goetz MB, Samore M (2015 Nov 01). Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010. Clin Infect Dis, 61(9), 1403-10.
  89. Chang A, Greene TH, Wang X, Kendrick C, Kramer H, Wright J, Astor B, Shafi T, Toto R, Lewis J, Appel LJ, Grams M (2015 Nov). The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant, 30(11), 1870-7.
  90. Umanath K, Jalal DI, Greco BA, Umeukeje EM, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Blumenthal SS, Sika M, Niecestro R, Koury MJ, Ma KN, Greene T, Lewis JB, Dwyer JP (2015 Oct). Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD. J Am Soc Nephrol, 26(10), 2578-87.
  91. Skarda DE, Yoder BA, Anstadt EE, Lally PA, Greene T, McFadden M, Rollins MD (2015 Oct). Epoprostenol Does Not Affect Mortality in Neonates with Congenital Diaphragmatic Hernia. Eur J Pediatr Surg, 25(5), 454-9.
  92. Gallicchio L, Miller SR, Kiefer J, Greene T, Zacur HA, Flaws JA (2015 Oct). Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study. Menopause, 22(10), 1098-107.
  93. Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE (2015 Sep). The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. Am J Kidney Dis, 66(3), 479-88.
  94. Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS (2015 Sep). Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. Am J Kidney Dis, 66(3), 459-68.
  95. Nelson RE, Samore MH, Jones M, Greene T, Stevens VW, Liu CF, Graves N, Evans MF, Rubin MA (2015 Sep). Reducing Time-dependent Bias in Estimates of the Attributable Cost of Health Care-associated Methicillin-resistant Staphylococcus aureus Infections: A Comparison of Three Estimation Strategies. Med Care, 53(9), 827-34.
  96. Stevens VW, Khader K, Nelson RE, Jones M, Rubin MA, Brown KA, Evans ME, Greene T, Slade E, Samore MH (2015 Sep). Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model. Infect Control Hosp Epidemiol, 36(9), 1024-30.
  97. Chen TK, Estrella MM, Astor BC, Greene T, Wang X, Grams ME, Appel LJ (2015 Aug). Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK). Nephrol Dial Transplant, 30(8), 1329-35.
  98. Jones BE, Sauer B, Jones MM, Campo J, Damal K, He T, Ying J, Greene T, Goetz MB, Neuhauser MM, Hicks LA, Samore MH (2015 Jul 21). Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study. Ann Intern Med, 163(2), 73-80.
  99. Beddhu S, Wei G, Marcus RL, Chonchol M, Greene T (2015 Jul 07). Light-intensity physical activities and mortality in the United States general population and CKD subpopulation. Clin J Am Soc Nephrol, 10(7), 1145-53.
  100. Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, Greene T, Larive B, Beck GJ, Gassman J, Kliger AS, Stokes JB (2015 Jul). Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials. Hemodial Int, 19(3), 386-401.
  101. Beddhu S, Filipowicz R, Chen X, Neilson JL, Wei G, Huang Y, Greene T (2015 Jun 23). Supervised oral protein supplementation during dialysis in patients with elevated C-reactive protein levels: a two phase, longitudinal, single center, open labeled study. BMC Nephrol, 16, 87.
  102. Meier JD, Zhang Y, Greene TH, Curtis JL, Srivastava R (2015 May). Variation in pediatric outpatient adenotonsillectomy costs in a multihospital network. Laryngoscope, 125(5), 1215-20.
  103. Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ (2015 Mar). Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis, 65(3), 394-402.
  104. Thomas A, Redd A, Khader K, Leecaster M, Greene T, Samore M (2015 Mar). Efficient parameter estimation for models of healthcare-associated pathogen transmission in discrete and continuous time. Math Med Biol, 32(1), 79-98.
  105. Huston HK, Abramowitz MK, Zhang Y, Greene T, Raphael KL (2015 Mar). Net endogenous acid production and mortality in NHANES III. Nephrology, 20(3), 209-15.
  106. Lewis JB, Sika M, Koury MJ, Chuang P, Schulman G, Smith MT, Whittier FC, Linfert DR, Galphin CM, Athreya BP, Nossuli AK, Chang IJ, Blumenthal SS, Manley J, Zeig S, Kant KS, Olivero JJ, Greene T, Dwyer JP (2015 Feb). Ferric citrate controls phosphorus and delivers iron in patients on dialysis. J Am Soc Nephrol, 26(2), 493-503.
  107. Greene, T (). Randomized controlled trials 5: Determining the sample size and power for clinical trials and cohort studies. Methods Mol Biol, 1281, 225-47.
  108. Ferrario M, Raimann JG, Larive B, Pierratos A, Thijssen S, Rajagopalan S, Greene T, Cerutti S, Beck G, Chan C, Kotanko P (2015). Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients. Blood Purif, 40(1), 99-108.
  109. Greene T (2015). Randomized controlled trials 5: Determining the sample size and power for clinical trials and cohort studies. Methods Mol Biol, 1281, 225-47.
  110. Greene T, Lahav Y, Kanat-Maymon Y, Solomon Z (2015). A Longitudinal Study of Secondary Posttraumatic Growth in Wives of Ex-POWs. Psychiatry, 78(2), 186-97.
  111. Skarda DE, Schall K, Rollins M, Andrews S, Olson J, Greene T, McFadden M, Thorell EA, Barnhart D, Meyers R, Scaife E (2015 Jan). A dynamic postoperative protocol provides efficient care for pediatric patients with non-ruptured appendicitis. J Pediatr Surg, 50(1), 149-52.
  112. Greene T, Teng CC, Inker LA, Redd A, Ying J, Woodward M, Coresh J, Levey AS (). Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study. Am J Kidney Dis, 64(6), 867-79.
  113. Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, Coresh J, Greene T, Levey AS (). GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. Am J Kidney Dis, 64(6), 848-59.
  114. Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J (). GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis, 64(6), 821-35.
  115. Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, Coresh J, Greene T, Levey AS (2014 Dec). GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. Am J Kidney Dis, 64(6), 848-59.
  116. Greene T, Teng CC, Inker LA, Redd A, Ying J, Woodward M, Coresh J, Levey AS (2014 Dec). Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study. Am J Kidney Dis, 64(6), 867-79.
  117. Skarda DE, Schall K, Rollins M, Andrews S, Olson J, Greene T, McFadden M, Thorell EA, Barnhart D, Meyers R, Scaife E (2014 Dec). Response-based therapy for ruptured appendicitis reduces resource utilization. J Pediatr Surg, 49(12), 1726-9.
  118. Khader K, Leecaster M, Greene T, Samore M, Thomas A (2014 Dec). Improved hidden Markov model for nosocomial infections. Math Med Biol, 31(4), 338-52.
  119. Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM (2014 Oct). Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol, 31(9), 799-804.
  120. Greene T, Lahav Y, Bronstein I, Solomon Z (2014 Oct). The role of ex-POWs' PTSD symptoms and trajectories in wives' secondary traumatization. J Fam Psychol, 28(5), 666-74.
  121. Raphael KL, Zhang Y, Ying J, Greene T (2014 Oct). Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease. Nephrology, 19(10), 648-54.
  122. Yan G, Norris KC, Greene T, Yu AJ, Ma JZ, Yu W, Cheung AK (2014 Aug 7). Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis. Clin J Am Soc Nephrol, 9(8), 1402-9.
  123. Porter A, Fischer MJ, Wang X, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Hiremath L, Kendrick C, Kusek JW, Norris KC, Thornley-Brown D, Greene T, Lash JP (2014 Aug). Quality of life and outcomes in African Americans with CKD. J Am Soc Nephrol, 25(8), 1849-55.
  124. Inker LA, Levey AS, Pandya K, Stoycheff N, Okparavero A, Greene T (2014 Jul). Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis, 64(1), 74-85.
  125. Martinson M, Ikizler TA, Morrell G, Wei G, Almeida N, Marcus RL, Filipowicz R, Greene TH, Beddhu S (2014 Jun 6). Associations of body size and body composition with functional ability and quality of life in hemodialysis patients. Clin J Am Soc Nephrol, 9(6), 1082-90.
  126. Nirula R, Millar D, Greene T, McFadden M, Shah L, Scalea TM, Stein DM, Magnotti LJ, Jurkovich GJ, Vercruysse G, Demetriades D, Scherer LA, Peitzman A, Sperry J, Beauchamp K, Bell S, Feiz-Erfan I, ONeill P, Coimbra R (2014 Apr). Decompressive craniectomy or medical management for refractory intracranial hypertension: an AAST-MIT propensity score analysis. J Trauma Acute Care Surg, 76(4), 944-52; discussion 952-5.
  127. Li L, Chang A, Rostand SG, Hebert L, Appel LJ, Astor BC, Lipkowitz MS, Wright JT, Kendrick C, Wang X, Greene TH (2014 Mar). A within-patient analysis for time-varying risk factors of CKD progression. J Am Soc Nephrol, 25(3), 606-13.
  128. Thiese MS, Hegmann KT, Wood EM, Garg A, Moore JS, Kapellusch JM, Foster J, Greene T, Stoddard G, Biggs J (2014 Feb). Low-back pain ratings for lifetime, 1-month period, and point prevalences in a large occupational population. Hum Factors, 56(1), 86-97.
  129. Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI (2014 Feb). Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis, 63(2), 236-43.
  130. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EV, Parker D, Macleod RS, Marrouche NF (2014 Feb). Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol, 7(1), 23-30.
  131. Lambers Heerspink HJ, Weldegiorgis M, Inker LA, Gansevoort R, Parving HH, Dwyer JP, Mondal H, Coresh J, Greene T, Levey AS, de Zeeuw D (2014 Feb). Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). Am J Kidney Dis, 63(2), 244-50.
  132. Jones M, Ying J, Huttner B, Evans M, Maw M, Nielson C, Rubin MA, Greene T, Samore MH (2014 Jan). Relationships between the importation, transmission, and nosocomial infections of methicillin-resistant Staphylococcus aureus: an observational study of 112 Veterans Affairs Medical Centers. Clin Infect Dis, 58(1), 32-9.
  133. Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, Kusek JW, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Vita JA, Greene T, Gassman JJ, Feldman HI (2014 Jan). Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis, 63(1), 104-12.
  134. Chang TI, Flythe JE, Brunelli SM, Muntner P, Greene T, Cheung AK, Chertow GM (2014 Jan). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. J Hum Hypertens, 28(1), 18-24.
  135. Chan CT, Chertow GM, Daugirdas JT, Greene TH, Kotanko P, Larive B, Pierratos A, Stokes JB (2014 Jan). Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial. Nephrol Dial Transplant, 29(1), 168-78.
  136. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ (2013 Dec 5). APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med, 369(23), 2183-96.
  137. Nkoy FL, Stone BL, Fassl BA, Uchida DA, Koopmeiners K, Halbern S, Kim EH, Wilcox A, Ying J, Greene TH, Mosen DM, Schatz MN, Maloney CG (2013 Dec). Longitudinal validation of a tool for asthma self-monitoring. Pediatrics, 132(6), e1554-61.
  138. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S (2013 Dec). Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol, 8(12), 2106-16.
  139. Yan G, Norris KC, Xin W, Ma JZ, Yu AJ, Greene T, Yu W, Cheung AK (2013 Dec). Facility size, race and ethnicity, and mortality for in-center hemodialysis. J Am Soc Nephrol, 24(12), 2062-70.
  140. Peterson GE, de Backer T, Contreras G, Wang X, Kendrick C, Greene T, Appel LJ, Randall OS, Lea J, Smogorzewski M, Vagaonescu T, Phillips RA (2013 Sep). Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease. Hypertension, 62(3), 518-25.
  141. Daugirdas JT, Leypoldt JK, Akonur A, Greene T, Depner TA (2013 Aug). Improved equation for estimating single-pool Kt/V at higher dialysis frequencies. Nephrol Dial Transplant, 28(8), 2156-60.
  142. Stock CJ, Carpenter L, Ying J, Greene T (2013 Jul-Aug). Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother, 47(7-8), 961-9.
  143. Rollins MD, Ward RM, Jackson WD, Mulroy CW, Spencer CP, Ying J, Greene T, Book LS (2013 Jun). Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg, 48(6), 1348-56.
  144. Yan G, Norris KC, Yu AJ, Ma JZ, Greene T, Yu W, Cheung AK (2013 Jun). The relationship of age, race, and ethnicity with survival in dialysis patients. Clin J Am Soc Nephrol, 8(6), 953-61.
  145. Sandweiss DR, Mundorff MB, Hill T, Wolfe D, Greene T, Andrews S, Glasgow TS (2013 May). Decreasing hospital length of stay for bronchiolitis by using an observation unit and home oxygen therapy. JAMA Pediatr, 167(5), 422-8.
  146. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S (2013 May). Serum bicarbonate and mortality in adults in NHANES III. Nephrol Dial Transplant, 28(5), 1207-13.
  147. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS (2013 May). Effect of frequent hemodialysis on residual kidney function. Kidney Int, 83(5), 949-58.
  148. Yan G, Cheung AK, Ma JZ, Yu AJ, Greene T, Oliver MN, Yu W, Norris KC (2013 Apr). The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol, 8(4), 610-8.
  149. DAgati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC (2013 Mar). Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol, 8(3), 399-406.
  150. Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A (2013 Feb). Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol, 8(2), 211-8.
  151. Li L, Greene T (2013). A weighting analogue to pair matching in propensity score analysis. Int J Biostat, 9(2), 215-34.
  152. Filipowicz R, Greene T, Wei G, Cheung AK, Raphael KL, Baird BC, Beddhu S (2013 Jan). Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clin J Am Soc Nephrol, 8(1), 26-32.
  153. Montford JR, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J (2013). Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23. Am J Nephrol, 37(3), 183-90.
  154. Randall O, Kwagyan J, Retta T, Jamerson K, Pogue V, Norris K, Ketete M, Xu S, Greene T, Wang X, Agodoa L (2013). Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis. Int J Nephrol, 2013, 120167.
  155. Rahman M, Greene T, Phillips RA, Agodoa LY, Bakris GL, Charleston J, Contreras G, Gabbai F, Hiremath L, Jamerson K, Kendrick C, Kusek JW, Lash JP, Lea J, Miller ER 3rd, Rostand S, Toto R, Wang X, Wright JT Jr, Appel LJ (2013 Jan). A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension, 61(1), 82-8.
  156. Greene T, Joffe M, Hu B, Li L, Boucher K (2013). The balanced survivor average causal effect. Int J Biostat, 9(2), 291-306.
  157. Jones M, Ying J, Huttner B, Evans M, Maw M, Nielson C, Rubin MA, Greene T, Samore MH (). Relationships Between the Importation, Transmission, and Nosocomial Infections of Methicillin-Resistant Staphylococcus aureus: An Observational Study of 112 Veterans Affairs Medical Centers. Clin Infect Dis.
  158. Seiki S, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J (2012 Dec). 25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease. Clin Nephrol, 78(6), 432-41.
  159. Gabbai FB, Rahman M, Hu B, Appel LJ, Charleston J, Contreras G, Faulkner ML, Hiremath L, Jamerson KA, Lea JP, Lipkowitz MS, Pogue VA, Rostand SG, Smogorzewski MJ, Wright JT, Greene T, Gassman J, Wang X, Phillips RA (2012 Nov). Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol, 7(11), 1770-6.
  160. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M (2012 Oct). Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis, 60(4), 567-75.
  161. Fassl BA, Nkoy FL, Stone BL, Srivastava R, Simon TD, Uchida DA, Koopmeiners K, Greene T, Cook LJ, Maloney CG (2012 Sep). The Joint Commission Children's Asthma Care quality measures and asthma readmissions. Pediatrics, 130(3), 482-91.
  162. Hung M, Nickisch F, Beals TC, Greene T, Clegg DO, Saltzman CL (2012 Aug). New paradigm for patient-reported outcomes assessment in foot & ankle research: computerized adaptive testing. Foot Ankle Int, 33(8), 621-6.
  163. Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, Kusek JW, Landis JR, Lash JP, Townsend RR, Weir MR, Feldman HI (2012 Aug). Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis, 60(2), 250-61.
  164. Mayer J, Greene T, Howell J, Ying J, Rubin MA, Trick WE, Samore MH (2012 Aug). Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis, 55(3), 364-70.
  165. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS (2012 Jul 5). Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med, 367(1), 20-9.
  166. Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM (2012 Jul). The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int, 82(1), 90-9.
  167. Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA (2012 May). Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol, 7(5), 851-5.
  168. Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA (2012 May). Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol, 7(5), 856-60.
  169. Esquitin R, Razzouk L, Peterson GE, Wright JT Jr, Phillips RA, De Backer TL, Baran DA, Kendrick C, Greene T, Reiffel J, Muntner P, Farkouh ME (2012 May-Jun). Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study. Pharmag, 6(3), 193-200.
  170. Hung M, Clegg DO, Greene T, Weir C, Saltzman CL (2012 Apr). A lower extremity physical function computerized adaptive testing instrument for orthopaedic patients. Foot Ankle Int, 33(4), 326-35.
  171. Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, Kendrick CA, James SH, Miller BW, Schulman G, Salusky IB, Kliger AS (2012 Apr). Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol, 23(4), 727-38.
  172. Hu B, Gadegbeku C, Lipkowitz MS, Rostand S, Lewis J, Wright JT, Appel LJ, Greene T, Gassman J, Astor BC (2012 Apr). Kidney function can improve in patients with hypertensive CKD. J Am Soc Nephrol, 23(4), 706-13.
  173. Jovanovich A, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J (2012 Apr). Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol, 7(4), 640-7.
  174. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr, Greene TH (2012 Apr). Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis, 59(4), 504-12.
  175. Murtaugh MA, Filipowicz R, Baird BC, Wei G, Greene T, Beddhu S (2012 Mar). Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant, 27(3), 990-6.
  176. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S (2012 Mar). Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging, 5(2), 251-61.
  177. Krishnamurthy VM, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL, Greene T, Beddhu S (2012 Feb). High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int, 81(3), 300-6.
  178. Hu B, Li L, Wang X, Greene T (). Nonparametric multistate representations of survival and longitudinal data with measurement error. Stat Med, 31(21), 2303-2317.
  179. Maloney CG, Antommaria AH, Bale JF, Ying J, Greene T, Srivastava R (2012). Factors associated with intern noncompliance with the 2003 Accreditation Council for Graduate Medical Education's 30-hour duty period requirement. BMC Med Educ, 12, 33.
  180. Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J (2012 Jan). Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Transl Res, 159(1), 4-11.
  181. Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB (2012 Jan). Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol, 23(1), 131-6.
  182. Sinsakul M, Sika M, Koury M, Shapiro W, Greene T, Dwyer J, Smith M, Korbet S, Lewis J (2012). The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients. Nephron Clinical Practice, 121(1-2), c25-9.
  183. Raphael KL, Wei G, Greene T, Baird BC, Beddhu S (2012). Cognitive function and the risk of death in chronic kidney disease. Am J Nephrol, 35(1), 49-57.
  184. Stevenson DA, Schwarz EL, Carey JC, Viskochil DH, Hanson H, Bauer S, Weng HY, Greene T, Reinker K, Swensen J, Chan RJ, Yang FC, Senbanjo L, Yang Z, Mao R, Pasquali M (2011 Dec). Bone resorption in syndromes of the Ras/MAPK pathway. Clin Genet, 80(6), 566-73.
  185. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S (2011 Nov). The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int, 80(10), 1080-91.
  186. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, DAgati VD, Friedman AL (2011 Oct). Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int, 80(8), 868-78.
  187. Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP (2011 Sep). Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int, 80(6), 670-8.
  188. Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, Chertow GM (2011 Aug). Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol, 22(8), 1526-33.
  189. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, Landray MJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B, Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T (2011 Jun). Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int, 79(12), 1331-40.
  190. Davis EM, Appel LJ, Wang X, Greene T, Astor BC, Rahman M, Toto R, Lipkowitz MS, Pogue VA, Wright JT Jr (2011 Jun). Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial. Hypertension, 57(6), 1061-8.
  191. Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, Beddhu S (2011 Jun). Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med, 124(6), 566.e1-7.
  192. Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, Zeeuw DD, Lambers Heerspink H, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I, on behalf of the Collaborative Study Group (). Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial. Am J Kidney Dis, (58), 729-36.
  193. Hung M, Clegg DO, Greene T, Saltzman CL (2011 Jun). Evaluation of the PROMIS physical function item bank in orthopaedic patients. J Orthop Res, 29(6), 947-53.
  194. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M, the HOST Investigators (). FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis. J Am Soc Nephrol, 22(10), 1913-1922.
  195. Yan G, Greene T (). Statistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trials. Clin Trials, 8(5), 571-80.
  196. Daugirdas JT, Greene T, Depner TA, Levin NW, Chertow GM (2011 May). Modeled urea distribution volume and mortality in the HEMO Study. Clin J Am Soc Nephrol, 6(5), 1129-38.
  197. Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR Jr, Kusek JW, Feldman HI (2011 Apr). Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol, 22(4), 773-81.
  198. Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL (2011 Mar). Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int, 79(6), 678-85.
  199. Stoycheff N, Pandya K, Okparavero A, Schiff A, Levey AS, Greene T, Stevens LA (2011 Mar). Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset. Nephrol Dial Transplant, 26(3), 848-57.
  200. Raphael KL, Wei G, Baird BC, Greene T, Beddhu S (2011 Feb). Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int, 79(3), 356-62.
  201. Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, Greene T, Coresh J, Levey AS (2011 Feb). Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int, 79(4), 471-7.
  202. Chang TI, Friedman GD, Cheung AK, Greene T, Desai M, Chertow GM (2011 Feb). Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. J Hum Hypertens, 25(2), 98-105.
  203. Trachtman H, Vento S, Gipson D, Wickman L, Gassman J, Joy M, Savin V, Somers M, Pinsk M, Greene T (2011). Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. BMC Nephrol, 12, 8.
  204. Damera S, Raphael KL, Baird BC, Cheung AK, Greene T, Beddhu S (2011 Jan). Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. Kidney Int, 79(2), 228-33.
  205. Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS (2011 Jan). Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol, 6(1), 184-91.
  206. Eggington JM, Greene T, Bass BL (2011). Predicting sites of ADAR editing in double-stranded RNA. Nat Commun, 2, 319.
  207. Leecaster M, Gesteland P, Greene T, Walton N, Gundlapalli A, Rolfs R, Byington C, Samore M (2011). Modeling the variations in pediatric respiratory syncytial virus seasonal epidemics. BMC Infect Dis, 11, 105.
  208. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS (2010 Dec 9). In-center hemodialysis six times per week versus three times per week. N Engl J Med, 363(24), 2287-300.
  209. Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M, Lewis JA, Randall OS, Hebert L, Wright JT Jr, Kendrick CA, Gassman J, Bakris G, Kopple JD, Appel LJ (2010 Dec). Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol, 21(12), 2131-42.
  210. Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ (2010 Nov). Serum bicarbonate and long-term outcomes in CKD. Am J Kidney Dis, 56(5), 907-14.
  211. Toto RD, Greene T, Hebert LA, Hiremath L, Lea JP, Lewis JB, Pogue V, Sika M, Wang X (2010 Nov). Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis, 56(5), 896-906.
  212. Chang TI, Paik J, Greene T, Miskulin DC, Chertow GM (2010 Oct). Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. Hemodial Int, 14(4), 478-85.
  213. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X (2010 Sep 2). Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med, 363(10), 918-29.
  214. Daugirdas JT, Greene T, Chertow GM, Depner TA (2010 Sep). Can rescaling dose of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men? Clin J Am Soc Nephrol, 5(9), 1628-36.
  215. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS (2010 Sep). Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis, 56(3), 486-95.
  216. Chawla V, Greene T, Beck GJ, Kusek JW, Collins AJ, Sarnak MJ, Menon V (2010 Sep). Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol, 5(9), 1582-7.
  217. Beddhu S, Baird B, Ma X, Cheung AK, Greene T (2010 Aug). Serum alkaline phosphatase and mortality in hemodialysis patients. Clin Nephrol, 74(2), 91-6.
  218. Alves TP, Wang X, Wright JT Jr, Appel LJ, Greene T, Norris K, Lewis J (2010 Aug). Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol, 21(8), 1361-9.
  219. Kwong YT, Stevens LA, Selvin E, Zhang YL, Greene T, Van Lente F, Levey AS, Coresh J (2010 Jul). Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis, 56(1), 39-49.
  220. Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP (2010 Jun). Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease. Kidney Int, 77(11), 1010-9.
  221. Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV (2010 Apr). Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int, 77(7), 637-44.
  222. Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, Bakoush O, Contreras G, Genuth S, Klintmalm GB, Poggio E, Rossing P, Rule AD, Weir MR, Kusek J, Greene T, Levey AS (2010 Feb). Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant, 25(2), 449-57.
  223. Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV, Stokes JB (2010 Jan-Feb). Effects of reduced intradialytic urea generation rate and residual renal clearance on modeled urea distribution volume and Kt/V in conventional, daily, and nocturnal dialysis. Semin Dial, 23(1), 19-24.
  224. Murtaugh MA, Ma KN, Greene T, Redwood D, Edwards S, Johnson J, Tom-Orme L, Lanier AP, Henderson JA, Slattery ML (2010 Autumn). Validation of a dietary history questionnaire for American Indian and Alaska Native people. Ethn Dis, 20(4), 429-36.
  225. Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T (2009 Dec). Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol, 4(12), 1901-6.
  226. Beddhu S, Ma X, Baird B, Cheung AK, Greene T (2009 Nov). Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol, 4(11), 1805-10.
  227. Daugirdas JT, Depner TA, Greene T, Silisteanu P (2009 Nov). Solute-solver: a web-based tool for modeling urea kinetics for a broad range of hemodialysis schedules in multiple patients. Am J Kidney Dis, 54(5), 798-809.
  228. Daugirdas JT, Meyer K, Greene T, Butler RS, Poggio ED (2009 Oct). Scaling of measured glomerular filtration rate in kidney donor candidates by anthropometric estimates of body surface area, body water, metabolic rate, or liver size. Clin J Am Soc Nephrol, 4(10), 1575-83.
  229. Li L, Hu B, Greene T (2009 Sep). A semiparametric joint model for longitudinal and survival data with application to hemodialysis study. Biometrics, 65(3), 737-45.
  230. Rogers RK, Stoddard GJ, Greene T, Michaels AD, Fernandez G, Freeman A, Nord J, Stehlik J (2009 Sep 1). Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea. Am J Cardiol, 104(5), 689-94.
  231. Beddhu S, Nigwekar SU, Ma X, Greene T (2009 Aug). Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease. Nephrol Dial Transplant, 24(8), 2482-8.
  232. Cheung AK, Greene T (). Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol, (20), 462-4.
  233. Young JM, Terrin N, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Sarnak MJ, Menon V (2009 Jun). Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol, 4(6), 1115-20.
  234. Greene T, Daugirdas J, Depner T, Gotch F, Kuhlman M (). Solute Clearances and Fluid Removal in the Frequent Hemodialysis Network Trials. Am J Kidney Dis, 53, 835-844.
  235. Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA, African American Study of Hypertension and Kidney Disease Collaborative Research Group (). Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy. Arch Intern Med, 169(17), 1587-94.
  236. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI (2009 May 21). Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med, 360(21), 2191-201.
  237. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009 May 5). A new equation to estimate glomerular filtration rate. Ann Intern Med, 150(9), 604-12.
  238. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V (2009 May). Uric acid and long-term outcomes in CKD. Am J Kidney Dis, 53(5), 796-803.
  239. Rogers K, Stehlik J, Stoddard G, Greene T, Collins S, Peacock WF, Maisel A, Clopton P, Michaels A (). Adjusting for Clinical Covariates Improves the Ability of BNP to Distinguish Cardiac from Non-Cardiac Dyspnea: A Sub-Study of HEARD-IT. Eur J Heart Fail, (11), 1043-1049.
  240. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS (2009 Mar). Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int, 75(6), 652-60.
  241. Greene T (2009 Mar). Randomized and observational studies in nephrology: how strong is the evidence? Am J Kidney Dis, 53(3), 377-88.
  242. Menon V, Kopple JD, Wang X, Beck GJ, Collins AJ, Kusek JW, Greene T, Levey AS, Sarnak MJ (2009 Feb). Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis, 53(2), 208-17.
  243. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA (2009 Jan). Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension, 53(1), 20-7.
  244. Yan G, Greene T (2008 Sep 20). Investigating the effects of ties on measures of concordance. Stat Med, 27(21), 4190-206.
  245. Xie D, Joffe MM, Brunelli SM, Beck G, Chertow GM, Fink JC, Greene T, Hsu CY, Kusek JW, Landis R, Lash J, Levey AS, OConner A, Ojo A, Rahman M, Townsend RR, Wang H, Feldman HI (2008 Sep). A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. Clin J Am Soc Nephrol, 3(5), 1332-8.
  246. Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM, Rocco MV (2008 Sep-Oct). Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender. Semin Dial, 21(5), 415-21.
  247. Unruh ML, Newman AB, Larive B, Dew MA, Miskulin DC, Greene T, Beddhu S, Rocco MV, Kusek JW, Meyer KB (2008 Sep). The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc, 56(9), 1608-17.
  248. Kanagasundaram NS, Greene T, Larive AB, Daugirdas JT, Depner TA, Paganini EP (2008 Jul). Dosing intermittent haemodialysis in the intensive care unit patient with acute renal failure--estimation of urea removal and evidence for the regional blood flow model. Nephrol Dial Transplant, 23(7), 2286-98.
  249. Menon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, Collins AJ, Kusek JW, Levey AS, Greene T (2008 Jun). Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int, 73(11), 1310-5.
  250. Heerspink HL, Greene T, Lewis JB, Raz I, Rohde RD, Hunsicker LG, Schwartz SL, Aronoff S, Katz MA, Eisner GM, Mersey JH, Wiegmann TB (2008 Jun). Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. Nephrol Dial Transplant, 23(6), 1946-54.
  251. Li L, Greene T (2008 Jun). Varying coefficients model with measurement error. Biometrics, 64(2), 519-26.
  252. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI (2008 May 14). Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA, 299(18), 2164-71.
  253. Joffe M, Greene T (). Related causal frameworks for surrogate outcomes. Biometrics, (65), 530-538.
  254. Appel L, Wright J, Greene T, Kusek J, Lewis J, Wang X, Lipkowitz M, Norris K, Bakris G, Rahman M, Contreras G, Rostand S, Kopple J, Aogodoa L (April 2008). Long-term effects of rennin-angiotensin-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med, 168(8), 832-839.
  255. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS (2008 Mar). Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis, 51(3), 395-406.
  256. Zhang P, Song PX, Qu A, Greene T (2008 Mar). Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models. Biometrics, 64(1), 29-38.
  257. Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan G (2008 Jan). Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol, 3(1), 69-77.
  258. Rubin MA, Mayer J, Greene T, Sauer BC, Hota B, Trick W, Jernigan JA, Samore MH (2008). An agent-based model for evaluating surveillance methods for catheter-related bloodstream infection. AMIA Annu Symp Proc, 631-5.
  259. Garg AX, Greene T, Levin NW (). A well-conducted randomized trial that establishes no benefit of therapy is an important medical advance. Nephrol Dial Transplant, 23(1), 52-5.
  260. Ix JH, Shlipak MG, Sarnak MJ, Beck GJ, Greene T, Wang X, Kusek JW, Collins AJ, Levey AS, Menon V (2007 Dec). Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int, 72(11), 1394-9.
  261. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G (2007 Nov). Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr, 17(6), 372-80.
  262. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS (2007 Oct). Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol, 18(10), 2749-57.
  263. Samore MH, Shen S, Greene T, Stoddard G, Sauer B, Shinogle J, Nebeker J, Harbarth S (2007 Oct). A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length of stay. Med Care, 45(10 Supl 2), S108-15.
  264. Madero M, Sarnak MJ, Wang X, Sceppa CC, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V (2007 Sep). Body mass index and mortality in CKD. Am J Kidney Dis, 50(3), 404-11.
  265. Castaneda-Sceppa C, Sarnak MJ, Wang X, Greene T, Madero M, Kusek JW, Beck G, Kopple JD, Levey AS, Menon V (2007 Sep). Role of adipose tissue in determining muscle mass in patients with chronic kidney disease. J Ren Nutr, 17(5), 314-22.
  266. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ (2007 Jul 3). Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med, 147(1), 19-27.
  267. Stevens LA, Manzi J, Levey AS, Chen J, Deysher AE, Greene T, Poggio ED, Schmid CH, Steffes MW, Zhang YL, Van Lente F, Coresh J (2007 Jul). Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis, 50(1), 21-35.
  268. Levey A, Coresh J, Greene T, March J, Stevens L, Kusek J, Van Lente F, for the Chronic Kidney Disease Collaboration (April 2007). Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem, 53(4), 766-772.
  269. Suri R, Garg A, Chertow G, Levin N, Rocco M, Greene T, Beck G, Gassman J, Eggers P, Star R, Ornt D, Kliger A (February 2007). The Frequent Hemodialysis Network (FHN) randomized trials: Study Design. Kidney Int, 71(4), 349-359.
  270. Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins AJ, Kopple JD (2006 Dec). Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis, 48(6), 879-88.
  271. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips R, Randall O, Rostand S, Sherer S, Toto R, Wright J, Xuelei W, Greene T, Appel L, Lewis J (November 2006). Cardiovascular outcomes in the african american study of kidney disease and hypertension (AASK) trial. Am J Kidney Dis, 48(5), 739-751.
  272. Norris KC, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A, Rostand S, Wang X, Appel LJ (2006 Oct). Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol, 17(10), 2928-36.
  273. Wang X, Lewis J, Appel L, Cheek D, Contreras G, Faulkner M, Feldman H, Gassman J, Lea J, Kopple J, Sika M, Toto R, Greene T (2006 Oct). Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. J Am Soc Nephrol, 17(10), 2900-9.
  274. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira A, Beck G, Kusek J, Collins A, Levey A, Sarnak M (September 2006). Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol, 17(9), 2599-2606.
  275. Chertow GM, Palevsky PM, Greene T (2006 Sep). Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician. Clin J Am Soc Nephrol, 1(5), 1124-7.
  276. Lash JP, Wang X, Greene T, Gadegbeku CA, Hall Y, Jones K, Kusek JW, Sika M, Unruh M (2006 Jun). Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management. Am J Kidney Dis, 47(6), 956-64.
  277. Ward RA, Greene T, Hartmann B, Samtleben W (2006 Apr). Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int, 69(8), 1431-7.
  278. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ (2006 Mar). Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis, 47(3), 469-77.
  279. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G (2006 Feb). Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol, 17(2), 546-55.
  280. Vonesh EF, Greene T, Schluchter MD (2006 Jan 15). Shared parameter models for the joint analysis of longitudinal data and event times. Stat Med, 25(1), 143-63.
  281. Levey A, Coresh J, Greene T, Stevens L, Zhang L, Hendricksen S, Kusek J, Van Lente F (2006 In Press). Performance of a Revised Modification of Diet in Renal Disease Study Equation to Estimate Glomerular Filtration Rate Using Age, Sex, Race, and Standardized Creatinine Assay. Ann Intern Med.
  282. Stevens L, Coresh J, Greene T, Levey A (2006 In Press). Using GFR estimating equations to assess kidney function: Application to chronic kidney disease. N Engl J Med.
  283. Stevens L, Greene T, Levey A (). Surrogate endpoints for clinical trials of kidney disease progression. Clin J Am Soc Nephrol.
  284. Gennari FJ, Hood VL, Greene T, Wang X, Levey AS (2006 Jan). Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: Modification of Diet in Renal Disease study findings. Clin J Am Soc Nephrol, 1(1), 52-7.
  285. Burrowes JD, Larive B, Chertow GM, Cockram DB, Dwyer JT, Greene T, Kusek JW, Leung J, Rocco MV (2005 Dec). Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study. Nephrol Dial Transplant, 20(12), 2765-74.
  286. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ (2005 Nov). Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol, 16(11), 3411-7.
  287. Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Star R, Toto R, Eknoyan G (2005 Nov). Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol, 16(11), 3371-80.
  288. Dwyer JT, Larive B, Leung J, Rocco MV, Greene T, Burrowes J, Chertow GM, Cockram DB, Chumlea WC, Daugirdas J, Frydrych A, Kusek JW (2005 Oct). Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study? Kidney Int, 68(4), 1766-76.
  289. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ (2005 Sep). Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis, 46(3), 455-63.
  290. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ (2005 Aug). C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int, 68(2), 766-72.
  291. Poggio ED, Nef PC, Wang X, Greene T, Van Lente F, Dennis VW, Hall PM (2005 Aug). Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis, 46(2), 242-52.
  292. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R (2005 Jul). Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect, 113(7), 894-9.
  293. Contreras G, Greene T, Agodoa LY, Cheek D, Junco G, Dowie D, Lash J, Lipkowitz M, Miller ER 3rd, Ojo A, Sika M, Wilkening B, Toto RD (2005 Jul). Blood pressure control, drug therapy, and kidney disease. Hypertension, 46(1), 44-50.
  294. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Selhub J, Levey AS, Sarnak MJ (2005 Apr). Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. Kidney Int, 67(4), 1539-46.
  295. Daugirdas JT, Greene T (2005 Mar). Dialysis dose as a determinant of adequacy. Semin Nephrol, 25(2), 76-80.
  296. Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS (2005 Mar 1). The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med, 142(5), 342-51.
  297. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand S, Miller EP, Smith W, and Bakris GL for the AASK Study Investigators (2005). Magnitude of Proteinuria Reduction Predicts Risk of End-Stage Renal Disease: Results of the AASK trial. Arch Intern Med, 165, 947-953.
  298. Dember LM, Kaufman JS, Beck GJ, Dixon BS, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kusek JW, Lawson JH, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI (2005). Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Clinical Trials, 2(5), 413-22.
  299. Dixon BS, Beck GJ, Dember LM, Depner TA, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kaufman JS, Lawson JH, Meyers CM, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI (2005). Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. Clinical Trials, 2(5), 400-12.
  300. Uhlig K, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS, Sarnak MJ (2005 Jan). Factors associated with lipoprotein(a) in chronic kidney disease. Am J Kidney Dis, 45(1), 28-38.
  301. Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT Jr (2004 Dec). A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol, 15(12), 3175-83.
  302. Leypoldt JK, Cheung AK, Deeter RB, Goldfarb-Rumyantzev A, Greene T, Depner TA, Kusek J (2004 Oct). Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments. Kidney Int, 66(4), 1669-76.
  303. Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB (2004 Jul). Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int, 66(1), 355-66.
  304. Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, Poole D, Uhlin L (2004 Jun). The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. Kidney Int, 65(6), 2321-34.
  305. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G (2004 Apr). Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int, 65(4), 1386-94.
  306. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ (2004 Mar). Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol, 61(3), 163-9.
  307. Phillips R, Faulkner M, Gassman J, Greene T, Jaen L, Kusek J, Lightfoot T, Norris K, Ojo A, Richardson A, Thompson, R, Wang X (2004). Recruitment of African Americans with chronic renal insufficiency into a multicenter clinical trial: The African American Study of Kidney Disease and Hypertension. J Clin Hypertens, 6, 430-6.
  308. Daugirdas JT, Greene T, Depner TA, Leypoldt J, Gotch F, Schulman G, Star R (2004 Jan). Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO Study. J Am Soc Nephrol, 15(1), 194-203.
  309. Depner TA, Greene T, Daugirdas JT, Cheung AK, Gotch FA, Leypoldt JK (2004 Jan-Feb). Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction. ASAIO J, 50(1), 85-93.
  310. Kanagasundaram NS, Greene T, Larive AB, Daugirdas JT, Depner TA, Garcia M, Paganini EP (2003 Dec). Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure. Kidney Int, 64(6), 2298-310.
  311. Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, Levin NW, Yan G (2003 Dec). Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis, 42(6), 1200-11.
  312. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G (2003 Dec). Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol, 14(12), 3251-63.
  313. Daugirdas JT, Greene T, Depner TA, Chumlea C, Rocco MJ, Chertow GM (2003 Sep). Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: effects of age, race, and gender. Kidney Int, 64(3), 1108-19.
  314. Gassman JJ, Greene T, Wright JT Jr, Agodoa L, Bakris G, Beck GJ, Douglas J, Jamerson K, Lewis J, Kutner M, Randall OS, Wang SR (2003 Jul). Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol, 14(7 Suppl 2), S154-65.
  315. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ (2003 Jul). Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis, 42(1), 44-52.
  316. Appel LJ, Middleton J, Miller ER 3rd, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT (2003 Jul). The rationale and design of the AASK cohort study. J Am Soc Nephrol, 14(7 Suppl 2), S166-72.
  317. Hebert LA, Greene T, Levey A, Falkenhain ME, Klahr S (2003 May). High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis, 41(5), 962-71.
  318. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003 Jan). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis, 41(1), 1-12.
  319. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT (). "Effect of dialysis dose and membrane flux in maintenance hemodialysis." New England Journal of Medicine 347, no. 25 (2002): 2010-2019. N Engl J Med, 347(25), 2010-2019.
  320. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS (2002 Dec). Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int, 62(6), 2208-15.
  321. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG (2002 Nov 20). Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA, 288(19), 2421-31.
  322. Sarnak MJ, Wang SR, Beck GJ, Kusek JW, Selhub J, Greene T, Levey AS (2002 Nov). Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. Am J Kidney Dis, 40(5), 932-9.
  323. Cheung AK, Yan G, Greene T, Daugirdas JT, Dwyer JT, Levin NW, Ornt DB, Schulman G, Eknoyan G (2002 Sep). Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol, 13(9), 2345-52.
  324. Wright JT Jr, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, Randall O, Rogers N, Smith MC, Massry S (2002 Jul 22). Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med, 162(14), 1636-43.
  325. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS (2002 May). Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis, 39(5), 920-9.
  326. Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, Levey AS (2002 May). Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol, 57(5), 327-35.
  327. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, OConnor D, Ojo A, Phillips R, Sika M, Wright J Jr (2001 Oct). Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis, 38(4), 744-53.
  328. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, OConnor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S (2001 Jun 6). Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA, 285(21), 2719-28.
  329. Greene T (2001 Jun). A model for a proportional treatment effect on disease progression. Biometrics, 57(2), 354-60.
  330. Schluchter MD, Greene T, Beck GJ (2001 Apr 15). Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease. Stat Med, 20(7), 989-1007.
  331. Allon M, Ornt DB, Schwab SJ, Rasmussen C, Delmez JA, Greene T, Kusek JW, Martin AA, Minda S (2000 Nov). Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group. Kidney Int, 58(5), 2178-85.
  332. Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, Eknoyan G (2000 Oct). Design and statistical issues of the hemodialysis (HEMO) study. Controlled Clin Trials, 21(5), 502-25.
  333. Mayfield JA, Reiber GE, Nelson RG, Greene T (2000 Jun). Do foot examinations reduce the risk of diabetic amputation? J Fam Pract, 49(6), 499-504.
  334. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS (2000 Apr). Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int, 57(4), 1688-703.
  335. Daugirdas JT, Greene T, Depner TA, Gotch FA, Star RA (1999 Nov). Relationship between apparent (single-pool) and true (double-pool) urea distribution volume. Kidney Int, 56(5), 1928-33.
  336. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999 Mar 16). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 130(6), 461-70.
  337. Depner TA, Greene T, Gotch FA, Daugirdas JT, Keshaviah PR, Star RA (1999 Feb). Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group. Kidney Int, 55(2), 635-47.
  338. Greene T, Depner TA, Daugirdas JT (1999). Mathematical coupling and the relationship between Kt/V and nPCR. Semin Dial, 12, 520-528.
  339. Cheung AK, Agodoa LY, Daugirdas JT, Depner TA, Gotch FA, Greene T, Levin NW, Leypoldt JK (1999 Jan). Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol, 10(1), 117-27.
  340. Teschan PE, Beck GJ, Dwyer JT, Greene T, Klahr S, Levy AS, Mitch WE, Snetselaar LG, Steinman TI, Walser M (1998 Nov). Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clin Nephrol, 50(5), 273-83.
  341. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah P, Levin NW, Schulman G (1997 Nov). Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int, 52(5), 1395-405.
  342. Hebert LA, Kusek JW, Greene T, Agodoa LY, Jones CA, Levey AS, Breyer JA, Faubert P, Rolin HA, Wang SR (1997 Sep). Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension, 30(3 Pt 1), 428-35.
  343. Kopple JD, Levey AS, Greene T, Chumlea WC, Gassman JJ, Hollinger DL, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS (1997 Sep). Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int, 52(3), 778-91.
  344. Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR (1997 Jun). Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int, 51(6), 2013-7.
  345. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE (1997 Jun). Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int, 51(6), 1908-19.
  346. Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C (1997 Feb). Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension, 29(2), 641-50.
  347. Mayfield JA, Reiber GE, Nelson RG, Greene T (1996 Jul). A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care, 19(7), 704-9.
  348. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE (1996 May). Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis, 27(5), 652-63.
  349. Nelson S, Greene T, Ernhart CB (1996). An epidemiological study of the effects of toxocara-canis infection on cognitive development. Neurotoxicol Teratol, 18(2), 167-174.
  350. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE (). Modification of Diet in Renal Disease (MDRD) Study Group. (1996). Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol, 7, 2616-2626.
  351. Levey AS, Beck GJ, Bosch JP, Caggiula AW, Greene T, Hunsicker LG, Klahr S, Modification of Diet in Renal Disease MDRD Study Group (1996). Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol, 7, 2097-2109.
  352. Olencki T, Finke J, Tubbs R, Tuason L, Greene T, McLain D, Swanson SJ, Herzog P, Stanley J, Edinger M, Budd GT, Bukowski RM (1996 Jan). Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy. J Immunother Emphasis Tumor Immunol, 19(1), 69-80.
  353. Levey AS, Bosch JP, Coggins CH, Greene T, Mitch WE, Schluchter MD, Schwab SJ, Modification of Diet in Renal Disease MDRD Study Group (1996). Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol, 7, 556-565.
  354. Ernhart CB, Greene T, Sokol RJ, Martier S, Boyd TA, Ager J (1995 Dec). Neonatal diagnosis of fetal alcohol syndrome: not necessarily a hopeless prognosis. Alcohol Clin Exp Res, 19(6), 1550-7.
  355. Meyers SM, Greene T, Gutman FA (1995 Dec). A twin study of age-related macular degeneration. Am J Ophthalmol, 120(6), 757-66.
  356. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995 Nov 15). Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med, 123(10), 754-62.
  357. Ikeda K, Klinkosz B, Greene T, Cedarbaum JM, Wong V, Lindsay RM, Mitsumoto H (1995 Apr). Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol, 37(4), 505-11.
  358. Ikeda K, Wong V, Holmlund TH, Greene T, Cedarbaum JM, Lindsay RM, Mitsumoto H (1995 Jan). Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease. Ann Neurol, 37(1), 47-54.
  359. Mitsumoto H, Ikeda K, Holmlund T, Greene T, Cedarbaum JM, Wong V, Lindsay RM (1994 Aug). The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol, 36(2), 142-8.
  360. Coggins CH, Dwyer JT, Greene T, Petot G, Snetselaar LG, Van Lente F (1994 Apr). Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis, 23(4), 514-23.
  361. Greene T, Bourgoignie JJ, Habwe V, Kusek JW, Snetselaar LG, Soucie JM, Yamamoto ME (1993 Nov). Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol, 4(5), 1221-36.
  362. Greene T, Ernhart CB (1993 Apr). Dentine lead and intelligence prior to school entry: a statistical sensitivity analysis. J Clin Epidemiol, 46(4), 323-39.
  363. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall PM, Steffes MW, and the Modification of Diet in Renal Disease MDRD Study and the Diabetes Control and Complications Trial DCCT Research Group (1993). Glomerular filtration rate measurements in clinical trials. J Am Soc Nephrol, 4, 1159-1171.
  364. Qu Y, Greene T, Piedmonte MR (1993). Symmetric Bernoulli distributions and generalized binomial distributions. Biom J, 5, 523-533.
  365. Goodkin DE, Rudick RA, Medendorp SV, Greene T, Schwetz KM, Fischer J, Daughtry M, Ross J, VanDyke C (1992). A randomized placebo-controlled double-masked clinical trial of weekly low-dose (7.5 mg) oral methotrexate in chronic progressive MS: Trial design, advantages of using a composite outcome, and observed toxicity. The Online Journal of Current Clinical Trials.
  366. Greene T, Ernhart CB, Boyd TA (1992 Apr 30). Contributions of risk factors to elevated blood and dentine lead levels in preschool children. Sci Total Environ, 115(3), 239-60.
  367. Ernhart CB, Greene T (1992 Jan). Postpartum changes in maternal blood lead concentrations. Br J Ind Med, 49(1), 11-3.
  368. Greene T, Ernhart CB, Sokol RJ, Martier S, Marler MR, Boyd TA, Ager J (1991 Dec). Prenatal alcohol exposure and preschool physical growth: a longitudinal analysis. Alcohol Clin Exp Res, 15(6), 905-13.
  369. Greene T, Ernhart CB (1991 Jul-Aug). Prenatal and preschool age lead exposure: relationship with size. Neurotoxicol Teratol, 13(4), 417-27.
  370. Ernhart CB, Greene T (1991). Low level lead exposure: Language development. Arch Environ Health, 45, 342-354.
  371. Rayens W, Greene T (1991). Covariance pooling and stabilization for classification. Comput Stat Data Anal, 11, 17-42.
  372. Greene T (1991). Descriptively sufficient subcollections of flats in matroids. Discrete Math, 87, 149-161.
  373. Greene T, Ernhart CB (1991). The use of cofactors in pediatric research. J Dev Behav Pediatr, 12, 378-385.
  374. Greene T, Ernhart CB, Ager J, Sokol R, Martier S, Boyd T (1991 Jan-Feb). Prenatal alcohol exposure and cognitive development in the preschool years. Neurotoxicol Teratol, 13(1), 57-68.
  375. Boyd TA, Ernhart CB, Greene TH, Sokol RJ, Martier S (1991 Jan-Feb). Prenatal alcohol exposure and sustained attention in the preschool years. Neurotoxicol Teratol, 13(1), 49-55.
  376. Greene T, Ernhart CB, Martier S, Sokol R, Ager J (1990 Dec). Prenatal alcohol exposure and language development. Alcohol Clin Exp Res, 14(6), 937-45.
  377. Greene T (1990). The depiction of linear association by matroids. Comput Stat Data Anal, 9, 251-269.
  378. Greene T, Rayens W (1989). Partially pooled covariance matrix estimation in discriminant analysis. Comm Stat Theor Meth, 18, 3679-3702.

Review

  1. Khanafer N, Daneman N, Greene T, Simor A, Vanhems P, Samore M, Brown KA (2017 Jul 24). Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970.LID - S1198-743X(17)30383-X [pii]LID - 10.1016/j.cmi.2017.07.012 [doi]. [Review]. Clin Microbiol Infect.
  2. Chan J, Johnson C, Beran-Maryott G, Cortez J, Greene TH, Nirula R, Heilbrun M (2016 May). Measuring the Impact of Whole-Body Computed Tomography on Hospital Length of Stay in Blunt Trauma. [Review]. Acad Radiol, 23(5), 582-7.
  3. Chopra V, Wesorick DH, Sussman JB, Greene T, Rogers M, Froehlich JB, Eagle KA, Saint S (2012 Feb). Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis. [Review]. Arch Surg, 147(2), 181-9.
  4. Suri RS, Nesrallah GE, Mainra R, Garg AX, Lindsay RM, Greene T, Daugirdas JT (2006 Jan). Daily hemodialysis: a systematic review. [Review]. Clin J Am Soc Nephrol, 1(1), 33-42.
  5. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH (2006 Jan). Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. [Review]. Clin Chem, 52(1), 5-18.
  6. Rocco MV, Cheung AK, Greene T, Eknoyan G (2005 Feb). The HEMO Study: applicability and generalizability. [Review]. Nephrol Dial Transplant, 20(2), 278-84.
  7. Greene T (2005). What did we learn from the HEMO Study? Implications of secondary analyses. [Review]. Contrib Nephrol, 149, 69-82.
  8. Paganini EP, Kanagasundaram NS, Larive B, Greene T (2001). Prescription of adequate renal replacement in critically ill patients. [Review]. Blood Purif, 19(2), 238-44.
  9. Greene T (2000). Are observational studies 'just as effective' as randomized clinical trials? [Review]. Blood Purif, 18(4), 317-22.
  10. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S (1999 Nov). Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. [Review]. J Am Soc Nephrol, 10(11), 2426-39.

Book Chapter

  1. Greene T, Cheung A, Krediet R (2002 In Press). Designing Clinical Trials in Dialysis.
  2. Greene T, Lai J, Levey AS (2001). Interpretation of Clinical Studies of Renal Disease. In Neilson EG, Couser WG (Eds.), Immunologic Renal Disease (2nd, pp. 887-914). Philadelphia: Lippincoll-Raven Publishers.

Conference Proceedings

  1. Greene T, Ernhart CB (1991). Controlling for measurement error in investigations of the effects of lead on development. International Conference on Heavy Metals in the Environment, Edinburgh, Scotland, 131-134.

Letter

  1. Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Cheung AK, Whelton PK, Chertow GM (2018 Aug). Risk-benefit profile of intensive blood pressure treatment - Authors' reply [Letter to the editor]. Lancet Diabetes Endocrinol, 6(8), 602.
  2. Cheung AK, Chertow GM, Greene T, Kimmel PL, Rahman M, Reboussin D, Rocco M (2018 Jul). Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease [Letter to the editor]. J Intern Med, 284(1), 106-107.
  3. Stock CJ, Carpenter L, Ying J, Greene T (2013 Dec). Reply to comment on "gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment" [Letter to the editor]. Ann Pharmacother, 47(12), 1743.
  4. Sarnak M, Levey A, Greene T (2005). Target blood pressure and kidney disease – Reply [Letter to the editor]. Ann Intern Med, 143, 311.
  5. Hebert LA, Greene T (2004). Proteinuria and blood pressure instead of urine volume are risk factors for progression of renal disease - Reply [Letter to the editor]. Am J Kidney Dis, 43(1), 193-194.
  6. Greene T, Appel L, Agodoa L, Wright J (2003). Antihypertensive drugs and renal protection [Letter to the editor]. JAMA, 1102-1103.
  7. Greene T, Cheung AK, Eknoyan G for the Hemodialysis HEMO Study Group (2003). Response to Scribner BH, Blagg CR, Friedman EA, Hoenich NA, Locatelli F. Effect of dialysis dose and membrane flux in maintenance hemodialysis [Letter to the editor]. N Engl J Med, 348, 1491-1493.
  8. Levey A, Greene T (1999). Prediction equation for glomerular filtration rate – Reply [Letter to the editor]. Ann Intern Med, 131, 630.
  9. Greene T, Ernhart CB (1993). Response to Letter to the Editor concerning Dentine lead and intelligence prior to school entry: A statistical sensitivity analysis [Letter to the editor]. J Clin Epidemiol, 46(4), 404-406.

Abstract

  1. Jones, M, Rubin, M, Greene, T, Leecaster, M, Spuhl, J, Nielson, C, Evans, M, Jain, R, Samore, M (). Comparing the Performance of Clinical History of MRSA vs. Active Surveillance at Individual and Hospital Ward Levels [Abstract]. Infectious Disease Society of America Conference, Vancouver, British Columbia, Canada.
  2. Jones, M, Ying, J, Greene, T, Leecaster, M, Huttner, B, Mayer, J, Rubin, M, Samore, M (). Analysis of MRSA Transmission Dynamics in the Veterans Affairs System [Abstract]. Annual Scientific Meeting of The Society for Healthcare Epidemiology of America.
  3. Mayer J, Howell J, Weir CR, Rubin MA, Greene T, Samore MH (). Use of electronic reporting and annotations by Infection Preventionists to describe differences in the application of surveillance criteria [Abstract]. Society for Healthcare Epidemiology of America.
  4. Mayer J, Howell J, Greene T, Rubin M, Ray W, Nordberg B, Hayden C, Nechodom P, Samore M (). Assessing inter-rater reliability of surveillance decisions by infection preventionists [Abstract]. Society for Healthcare Epidemiology of America.
  5. Greene T, Coresh J, Poggio E, Schmid C, Stark P, Stevens L, Zhang L, Levey A (2005). A Statistical Explanation for Different Relationships of Serum Creatinine (Scr) vs. GFR across Populations. Preliminary Results [Abstract]. Journal of the American Society of Nephrology, 16.
  6. Wang X, Lewis J, Appel L, Cheek D, Contreras G, Faulkner M, Gassman J, Lea J, Kopple J, Sika M, Toto R, Greene T (2005). Validation of Serum Creatinine (Scr)-Based Outcomes for Longitudinal Studies of CKD [Abstract]. Journal of the American Society of Nephrology, 16.
  7. Suri R, Nesrallah G, Mainra R, Garg A, Lindsay R, Greene T, Daugirdas J (2005). Daily Hemodialysis - A Systematic Review [Abstract]. Journal of the American Society of Nephrology, 16.
  8. Levey A, Coresh J, Greene T, Marsh J, Stevens L, Kusek J, Van Lente F (2005). Expressing the MDRD Study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values [Abstract]. Journal of the American Society of Nephrology, 16.
  9. Memon V, Sarnak M, Greene T, Pereira A, Wang X, Beck G, Kusek J, Collins A, Levey A, Shlipak M (2005). Homocysteine: Is It an Independent Predictor of Mortality in Chronic Kidney Disease? [Abstract]. Journal of the American Society of Nephrology, 16.
  10. Greene T, Gassman J, Gipson D, Hogg R, Kaskel F, Moxey-Mims M, Fine R, Trachtman H, Watkins S, Siegel N (2005). Multicenter Randomized Clinical Trial of FSGS in Children and Young Adults [Abstract]. Journal of the American Society of Nephrology, 16.
  11. Coresh J, Stevens L, Greene T, Eggers P, Kusek J, Van Lente F, Zhang L, Schmid C, Stark P, Rohde R, Rodby R, Levey A (2005). Comparison of GFR Estimating Equations Using Serum Cystatin and Creatinine: A Pooled Analysis of 1706 Individuals [Abstract]. Journal of the American Society of Nephrology, 16.
  12. Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins A, and Kopple JD (2004). The Effect of Very Low Protein Diet on Progression of Kidney Disease and Mortality in Modification of Diet in Renal Disease Study B [Abstract]. Journal of the American Society of Nephrology, 15, 586A.
  13. Dwyer JT, Leung J, Larive B, Rocco MV, Greene T, Burrowes J, Chertow GM, Cockram DB, Chumlea WC, Daugirdas J, Frydrych A, Kusek JW and the HEMO Study Group (2004). Are Common Nutritional Risk Factors Among the Strongest Mortality Predictors When Also Considering Case-Mix? Results from the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 15, 382A.
  14. Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins A, and Kopple JD (2004). Effect of Low Protein Diet on Progression of Kidney Disease in the Modification of Diet in Renal Disease Study A: Long-Term Follow-Up [Abstract]. Journal of the American Society of Nephrology, 15, 586A.
  15. Menon V, Greene T, Pereira A, Wang X, Beck G, Kusek J, Collins A, Levey A, Sarnak M (2004). C-reactive protein as a predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease [Abstract]. Journal of the American Society of Nephrology, 15, 125A.
  16. Menon V, Greene T, Pereira A, Wang X, Beck J, Kusek J, Collins A, Levey A, Sarnak M (2004). Insulin resitance as a predictor of all-cause and cardiovascular mortality in chronic kidney disease [Abstract]. Journal of the American Society of Nephrology, 15, 128A.
  17. Daugirdas J, Allon M, Depner T, Greene T, Ornt D, Schwab S and the HEMO Study Group (2003). Effect of change in vascular access on outcome in the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 14, 238A.
  18. Norris K, Bourgoignie J, Gassman J, Hebert L, Middleton J, Phillips R, Randall O, Rostand S, Sherer S, Toto R, Wright J, Wang X, Kopple J, Lewis J, Greene T for the AASK Study Group (2003). Cardiovascular outcomes in the African American (AA) Study of Hypertension and Kidney Disease (AASK) [Abstract]. Journal of the American Society of Nephrology, 14, 673A.
  19. Lash JP, Gadegbeku C, Greene T, Hall Y, Jones K, Kusek JW, Sika M, Wang X for the AASK Study Group (2003). Longitudinal effects of blood pressure level and antihypertensive regimen on quality of life in the AASK Study [Abstract]. Journal of the American Society of Nephrology, 14, 678A.
  20. Contreras G, Agodoa LY, Cheek D, Dowie D, Greene T, Lash J, Lipkowitz M, Miller PER, Ojo A, Sika M, Wilkening B, Toto R for the AASK Study Group (2003). Lower blood pressure control and first line antihypertensives in the AASK Trial [Abstract]. Journal of the American Society of Nephrology, 14, 815A.
  21. Cheung AK, Agodoa L, Daugirdas JT, Greene T, Levey AS, Milford E, Ornt DB, Rocco M, Sarnak M, Yan G, Eknoyan G and the HEMO Study Group (2003). Predictive value of blood pressure for mortality in chronic hemodialysis patients changes with duration of follow-up [Abstract]. Journal of the American Society of Nephrology, 14, 2A.
  22. Daugirdas J, Levin N, Bailey J, Beck G, Cheung A, Greene T, Leypoldt JK, Martin A and the HEMO Study Group (2003). Occurrence of intradialytic hypotension as a risk factor for mortality in the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 14, 711A.
  23. Greene T, Daugirdas J, Cheung A, Depner T, Gotch F, Levin N, Leypoldt JK, Schulman G and the HEMO Study Group (2003). Indices derived from modeled urea distribution volume are associated with mortality in the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 14, 212A.
  24. Uhlig K, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS, Sarnak MJ (2002). Are lipoprotein(a) level and apoprotein(a) size risk factors for progression of non-diabetic kidney disease [Abstract]. Journal of the American Society of Nephrology, 13, 465A.
  25. Eknoyan G, Greene T for the HEMO Study Group (2002). Primary Results from the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 13, 421A.
  26. Appel LJ, Bakris G, Douglas-Baltimore J, Greene T, Kopple J, Massry S, Wang X for the AASK Research Group (2002). The relationship between achieved blood pressure and renal outcomes in the African American Study of Kidney Disease (AASK) [Abstract]. Journal of the American Society of Nephrology, 13, 423A.
  27. Dember L, Kaufman J, Beck G, Dixon B, Gassman J, Greene T, Himmelfarb J, Hunsicker L, Kusek J, Middleton J, Schwab S, Feldman H and the DAC Study Group (2002). Dialysis Access Consortium (DAC) Trial Design: Clopidogrel prevention of early AV fistula thrombosis [Abstract]. Journal of the American Society of Nephrology, 13, 229A.
  28. Dixon B, Greene T, Beck G, Dember LM, Gassman J, Himmelfarb J, Hunsicker LG, Kaufman J, Kusek J, Middleton JP, Schwab SJ, Feldman HI and the DAC Study Group (2002). Dialysis Access Consortium (DAC) Trial Design: Sustained-release Dipyridamole plus aspirin to prevent graft failure [Abstract]. Journal of the American Society of Nephrology, 13, 232A.
  29. Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wright J for the AASK Study Group (2002). Effects of interventions on outcomes based on serum creatinine in the African American Study of Kidney Disease (AASK) [Abstract]. Journal of the American Society of Nephrology, 13, 423A.
  30. Middleton J, Greene T et al for the AASK Study Group (2002). Renal outcomes in the context of an acute GFR effect of dihydropyridine CCBs in the African American Study of Kidney Disease (AASK) [Abstract]. Journal of the American Society of Nephrology, 13, 3A.
  31. Uhlig K, Wang S, Beck G, Kusek J, Marcovina S, Greene T, Levey A, Sarnak M (2002). Association of level of kidney function on lipoprotein(a) levels in non-diabetic kidney disease [Abstract]. Journal of the American Society of Nephrology, 13, 467A.
  32. Feldman H, Landis JR, Gaughan C, Joffe M, Xie S, Greene T, Franklin-Becker E, Kusek J, Beck G, Levey A, the CRIC Study Group (2002). MDRD Equation for measuring changes in GFR in longitudinal studies [Abstract]. Journal of the American Society of Nephrology, 13, 222A.
  33. Lea J, Bakris G, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Miller E, Rostand S, Smith W for the AASK Study Group (2002). Association of baseline proteinuria and GFR with progression of kidney disease in the African American Study of Kidney Disease (AASK) [Abstract]. Journal of the American Society of Nephrology, 13, 422A.
  34. Rocco M, Owen W, Greene T, Radeva M, Delmez J, Kaufman A, Kusek J, Ornt D, Eknoyan G and the HEMO Study Group (2001). Predictors of elevated c-reactive protein levels in chronic hemodialysis patients: results from the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 12, 362A.
  35. Kanagasundaram N, Greene T, Larive B, Garcia M, Daugirdas J, Depner T, Paganini E, PICARD Study Group (2001). Variability of intermittent hemodialysis (IHD) dose in the ICU patient with acute renal failure (ARF) [Abstract]. Journal of the American Society of Nephrology, 12, 450A.
  36. Miller E, Appel L, Cheek D, Greene T, Kuesk J, Lash J, Schulman G, and the AASK Study Group (2001). Ramipril-and Amlodipine-based therapy to prevent proteinuria: Results from the African American Study of Kidney Disease (AASK) [Abstract]. Journal of the American Society of Nephrology, 12, 469A.
  37. BS Dixon, T Greene, LG Hunsicker, AS Levey and the MDRD Study Group (2001). Estimating urine creatinine excretion: application to estimate 24-hour urine protein from a spot urine sample [Abstract]. Journal of the American Society of Nephrology, 12, 99A.
  38. Kaysen GA Daugirdas JT, Greene T, Kimmel PL, Levin NW, Radeva M, Schulman GW, Toto RD and the HEMO Study Group (2001). C reactive protein levels greater than 13 mg/dL and enPCR less than 1 are associated with reduced serum creatinine and albumin in hemodialysis patients [Abstract]. Journal of the American Society of Nephrology, 12, 389A.
  39. Depner T, Bhat A, Kumar V, Greene T (2001). Uremic toxicity: A designer solute approach based on clinical outcome [Abstract]. Journal of the American Society of Nephrology, 12, 447A.
  40. Norris K, Agodoa L, Douglas M, Gayle R, Greene T, Lea J, Wright J (2001). Differences in renal outcomes between ACE Inhibitor (ACEI) and dihydropyridine calcium channel blocker (DHPCCP) persist after adjustment for blood pressure (BP) and add-on drugs for hypertensive kidney disease [Abstract]. Journal of the American Society of Nephrology, 12, 233A.
  41. LA Hebert, T Greene, ME Falkenhain, A Levey, L Hunsicker, SR Wang, G Beck, S Klahr and the MDRD Study Group (2001). Greater urine volume (UV) is associated with greater proteinuria (P) in both the polycystic kidney disease (PKD) and non-PKD patients of the Modification of Diet in Renal Disease (MDRD) Study [Abstract]. Journal of the American Society of Nephrology, 12, 73A.
  42. Kanagasundaram N, Greene T, Larive B, Garcia M, Daugirdas J, Depner T, Paganini E, PICARD Study Group (2001). Estimating urea distribution volume (V) in ICU patients receiving intermittent hemodialysis (IHD) for acute renal failure (ARF) [Abstract]. Journal of the American Society of Nephrology, 12, 450A.
  43. Depner T, Bhat A, Greene T (2001). Solute seclusion (SS): An alternative to the peak concentration (PC) hypothesis [Abstract]. Journal of the American Society of Nephrology, 12, 447A.
  44. Kanagasundaram N, Greene T, Larive B, Garcia M, Daugirdas J, Depner T, Paganini E, PICARD Study Group (2001). Dosing intermittent hemodialysis (IHD) in the Acute Renal Failure (ARF) patient – blood-side methods overestimate urea removal [Abstract]. Journal of the American Society of Nephrology, 12, 450A.
  45. Kanagasundaram N, Greene T, Larive B, Garcia M, Daugirdas J, Depner T, Paganini E, PICARD Study Group (2001). Intermittent hemodialysis (IHD) in ICU acute renal failure (ARF) – Access recirculation in termorary veno-venous (VV) catheters [Abstract]. Journal of the American Society of Nephrology, 12, 4518A.
  46. Coresh J, Astor B, Muntner M, Greene T, Levey A (2001). Estimates of glomerular filtration rate in the United States population: Third National Health and Nutrition Examination (NHANES III) [Abstract]. Journal of the American Society of Nephrology, 12, 198A.
  47. Schulman G, Delmez J, Greene T, Kimmel P, Martin A, Ornt D, Levey A, Levin N and the HEMO Study Group (2000). Experience with two dialyzers in series in the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 11, 177A.
  48. Hunsicker LG, Greene T, Levey A, Klahr S (2000). Blood pressure reduction reduces progression of renal insufficiency in proteinuric patients by mechanisms independent of reduction in proteinuria [Abstract]. Journal of the American Society of Nephrology, 11, 150A.
  49. Levey A, Greene T, Kusek J, Beck G and the MDRD Study Group (2000). A simplified equa¬tion to predict glomerular filtration rate from serum creatinine [Abstract]. Journal of the American Society of Nephrology, 11, 155A.
  50. Ornt D, Greene T, Kaufman A, Minda S, Rehm-McGillicuddy J, Weiss B, Kusek J, and the HEMO Study Group (2000). Measurement of adherence in a hemodialysis (HD) therapy clinical trial: assessment of prescribed HD dose on sampling versus non-sampling days [Abstract]. SCT.
  51. Depner T, Greene T, Daugirdas J, Gotch F, Kusek J, Leypoldt J, McGillicuddy JR for the HEMO Study (2000). Simultaneous estimation of delivered blood flow and in-vivo urea mass transfer coefficient from the cross-dialyzer extraction ratio [Abstract]. Journal of the American Society of Nephrology, 11, 317A-318A.
  52. Hebert L, Greene T, Levey A, Hunsicker L, Klahr S, Wang SR (2000). High urine volume (UV) and low osmolality (Uosm) are risk factors for faster progression of renal disease (RD), especially in polycystic kidney disease (PKD) patients [Abstract]. Journal of the American Society of Nephrology, 11, 148A.
  53. Lipkowitz M, Agodoa L, Bakris G, Dowie D, Greene T, Jaen L, Middleton J, and the AASK Study Group (2000). Relationship between uric acid and blood pressure, renal disease and cardiovascular disease in African American Study of Kidney Disease and Hypertension (AASK) participants [Abstract]. Journal of the American Society of Nephrology, 11, 156A.
  54. Daugirdas J, Chumlea C, Depner T, Greene T, Husak S, Rocco M for the HEMO Study (2000). Anthro¬pometric estimates of total body water overestimate properly computed kinetic urea volume [Abstract]. Journal of the American Society of Nephrology, 11, 317A.
  55. Levey A, Greene T, Hebert L, Hunsicker L, Beck G, and the MDRD Study Group (2000). Urine protein-to-creatinine ratio as a predictor of progression of renal disease [Abstract]. Journal of the American Society of Nephrology, 11, 155A.
  56. Hebert LA, Greene T, Hunsicker LG, Levey AS, Wang S, and the MDRD Study Group (1999). Relationship of urine volume and urine osmolality to the progression of renal disease in the Modification of Diet in Renal Disease (MDRD) Study [Abstract]. Journal of the American Society of Nephrology, 10, 165-166A.
  57. Cheung A, Daugirdas J, Dwyer J, Greene T, Levin N, Ornt D, Schulman G, Yan G, Eknoyan G and the HEMO Study Group (1999). Seasonal variations in clinical and laboratory parameters in chronic hemodialysis patients [Abstract]. Journal of the American Society of Nephrology, 10, 236A.
  58. Daugirdas J, Beck G, Depner T, DeVita M, Greene T, Miller J, Rocco M and the HEMO Study Group (1999). Accurate estimation of equilibrated PCRn by modifying the output of a single-pool UKM program [Abstract]. Journal of the American Society of Nephrology, 10, 328A.
  59. Leypoldt J, Cheung A, Gassman J, Greene T, Levey A, Macon E, Rocco M, Star R, and the HEMO Study Group (1999). Sodium removal and extracellular volume measurements in chronic hemodialysis patients [Abstract]. Journal of the American Society of Nephrology, 10, 330A.
  60. Greene T, Beck G, Wang S, Kusek J, Levey A, and the MDRD Study Group (1999). The effect of low protein diet in the MDRD Study A is dependent on the underlying rate of disease progression [Abstract]. Journal of the American Society of Nephrology, 10, 165A.
  61. Wang SR, Greene T, Beck G, Gassman J, Kusek J, Levey A, and the MDRD Study Group (1999). Variability of indices of kidney function in studies of chronic reneal disease [Abstract]. Controlled Clinical Trials, 20, 80S.
  62. Greene T, Daugirdas J, Beck G, Depner T, Ornt D, Schulman G, Star R, Eknoyan G and the HEMO Study Group (1999). Effect of variability on performance standards for achieving a minimum spKt/V goal [Abstract]. Journal of the American Society of Nephrology, 10, 330A.
  63. Yan G, Greene T, Beck G, Kusek J, Leung J, Levey A, Paranandi L, and the HEMO and MDRD Study Groups (1999). Bias in longitudinal assessments of protein intake due to seasonal variations in studies of patients with kidney disease [Abstract]. Controlled Clinical Trials, 20, 63S.
  64. Lewis JB, Agodoa L, Cheek D, Greene T, Middleton J, OConnor D, Wright J and the AASK Study Group (1998). Estimation of GFR from serum creatinine in the African American Study of Kidney Disease and Hypertension (AASK) [Abstract]. Journal of the American Society of Nephrology, 9, 153A.
  65. Levey AS, Bosch JP, Breyer Lewis JA, Greene T, Rogers N, Roth D (1998). Predicting GFR from serum creatinine in the MDRD Study: a correction [Abstract]. Journal of the American Society of Nephrology, 9, 153A.
  66. Daugirdas J, Depner T, Gotch F, Greene T, Levin N, Schulman G, Star R, Yan G and the HEMO Study Group (1998). Predictors of urea rebound [Abstract]. Journal of the American Society of Nephrology, 296A.
  67. Hebert LA, Appel L, Cleveland W, Greene T, Jamerson K, Kopple J, Pogue V and the AASK Study Group (1998). Cigarette smoking is associated with lower glomerular filtration rate in African Americans with hypertensive nephrosclerosis [Abstract]. Journal of the American Society of Nephrology, 9, 149A.
  68. Levey AS, Greene T, Burkart J and MDRD Study Group (1998). Comprehensive assessment of the level of renal function at the initiation of dialysis in the MDRD Study [Abstract]. Journal of the American Society of Nephrology, 9, 153A.
  69. Leypoldt J, Cheung A, Daugirdas J, Greene T, Levin N, Ornt D, Schulman G and the HEMO Study Group (1998). Evaluation of hemodialyzer clearance of b2-microglobulin using predialysis and postdialysis plasma concentrations [Abstract]. Journal of the American Society of Nephrology, 9, 299A.
  70. Daugirdas J, Depner T, Gotch F, Greene T, Schulman G, Star R and the HEMO Study Group (1998). Validation of a corrected 30-min post BUN sample to compute eKt/V from urea rebound measured 60 minutes postdialysis [Abstract]. Journal of the American Society of Nephrology, 9, 295A.
  71. Levey AS, Bosch JP, Breyer JA, Greene T, Rogers N, Roth D (1997). Modification of Diet in Renal Disease (MDRD) Study Group. Predicting GFR from serum creatinine in the Modification of Diet in Renal Disease Study [Abstract]. 30th American Society of Nephrology Annual Meeting.
  72. Coronado B, Beck GJ, Greene T, Kusek JW, Levey AS (1997). Modification of Diet in Renal Disease (MDRD) Study Group. Cardiovascular disease risk factors and GFR in the MDRD Study [Abstract]. 30th American Society of Nephrology Annual Meeting.
  73. Daugirdas J, Depner T, Greene T, Kaufman A, Leypoldt K, Schulman G and the HEMO Study Group (1997). Effect of vascular access type and blood draw method on recirculation and rebound in the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 8, 280A.
  74. Lewis JL, Chertow GM, Paganini EP, Himmelfarb J, Ikizler TA, Greene T, Mehta RL (1997). A multicenter survey of patient characteristics, practice patterns, and outcomes in critically ill patients with acute renal failure (ARF) [Abstract]. Journal of the American Society of Nephrology, 8, 142A.
  75. Eknoyan G, Agodoa L, Beck G, Daugirdas J, Greene T, Kusek J, Levin N and the HEMO Study Group (1997). Adequacy of delivered dialysis doses in the HEMO Study: an interim report [Abstract]. Journal of the American Society of Nephrology, 8, 282A.
  76. Greene P, Brooks D, Gassman J, Greene T, Hall Y, Kusek J, Phillips R, Smith D, Wilkening B, and the AASK Study Group (1997). Pill counting and attainment of blood pressure goals in the African American Study of Kidney Disease and Hypertension (AASK) [Abstract]. Controlled Clinical Trials, 18, 68S-69S.
  77. Kutner M, Agodoa L, Gassman J, Glassock R, Greene T, Olutade B, Randall O (1997). AASK Study Group. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK) [Abstract]. Ethnicity & Disease, 7, S44.
  78. Depner T, Cheung A, Daugirdas J, Gotch F, Greene T, Leypoldt K from the Hemodialysis HEMO Study (1996). Adjustments required to accurately predict in vivo hemodialysis urea clearance from in vivo derived constants [Abstract]. Journal of the American Society of Nephrology, 7, 1510.
  79. Daugirdas J, Greene T, Depner T, Gotch F, Keshaviah P, Star R from the Hemodialysis HEMO Study (1996). Estimation of double pool volume from single pool urea distribution volume [Abstract]. Journal of the American Society of Nephrology, 7, 1510.
  80. Leypoldt J, Cheung A, Clark W, Daugirdas J, Gotch F, Greene T, Levin N from the Hemodialysis HEMO Study (1996). Characterization of low and high flux dialyzers with reuse in the HEMO Study: Interim Report [Abstract]. Journal of the American Society of Nephrology, 7, 1518.
  81. Daugirdas J, Greene T, Levin N, Maroni B, Schulman G, Star R from the Hemodialysis HEMO Study (1996). Modeled/anthropometric volume ratios: effect of age, race, and different formulas [Abstract]. Journal of the American Society of Nephrology, 7, 1510.
  82. Beck G, Caggiula A, Greene T, Kusek J, Levey A (1996). A pilot study for feasibility of long-term patient follow-up after the end of a clinical trial [Abstract]. Controlled Clinical Trials, 17, 95S.
  83. Mayfield J, Nelson R, Reiber G and Greene T (1996 In Press). Foot risk factors, health care, and amputation risk in Pima Indians with diabetes [Abstract]. Association for Health Services Research.
  84. Paranandi L, Wang S-R, Greene T, Gassman JJ, Beck GJ, Lazarus JM and the MDRD Study Group (1995). Considerations regarding "measurement visits" during follow-up of clinical trials [Abstract]. Controlled Clinical Trials, 16, 120S-121S.
  85. Depner TA, Gotch F, Daugirdas JT, Greene T, Kaufman AM from the Hemodialysis HEMO Study (1995). Monitoring dialysis therapy using estimates of amount of urea removed and mean urea volume [Abstract]. Journal of the American Society of Nephrology, 6, 597.
  86. Porush JG, Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Milas NC, Paranandi L, Peterson JC, Rauch S, Soucie JM, Stollar C (1995). Modification of Diet in Renal Disease (MDRD) Study Group. Efficacy of anti-hypertensive interventions in reducing blood pressure in the MDRD Study [Abstract]. Journal of the American Society of Nephrology, 6, 400.
  87. Levey AS, Beck GJ, Bosch JP, Caggiula AW, Greene T, Hunsicker LG, Klahr S (1995). Modification of Diet in Renal Disease (MDRD) Study Group. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on GFR in the MDRD Study [Abstract]. Journal of the American Society of Nephrology, 6, 395.
  88. Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T from the Hemodialysis HEMO Study (1995). Dialyzer urea mass transfer-area coefficient (KoA) increases at high dialysate flow rate [Abstract]. Journal of the American Society of Nephrology, 6, 606.
  89. Greene T, Beck GJ, Gassman JJ, Kutner MH, Paranandi L, Wang S-R and the MDRD Study Group and the AASK Study Group (1995). Comparison of time-to-event and slope-based analyses in nephrology clinical trials [Abstract]. Controlled Clinical Trials, 16, 65S.
  90. Daugirdas JT, Depner TA, Gotch F, Keshaviah P, Greene T, Schulman G, Levin N (1995). HEMO Study Group Comparison of methods to predict the equilibrated Kt/V (eKTV) in the HEMO Study [Abstract]. Journal of the American Society of Nephrology, 6, 596.
  91. Peterson JC, Greene T, Klahr S, Burkart JM, Hebert LA, King AJ, Massry SG, Seifter JL (1994). Modification of Diet in Renal Disease (MDRD) Study Group. Effect of reducing proteinuria (PR) on subsequent glomerular filtration rate (GFR) decline in patients with chronic renal failure (CRF) [Abstract]. Journal of the American Society of Nephrology, 5, 339.
  92. Levey AS, Beck GJ, Caggiula AW, Greene T, Kusek JW, Striker GE, Klahr S (1994). Modification of Diet in Renal Disease (MDRD) Study Group. Trends toward a beneficial effect of a low protein diet during additional follow-up in the Modification of Diet in Renal Disease Study [Abstract]. Journal of the American Society of Nephrology, 5, 336.
  93. Greene T, Greer J, Beck GJ, Gassman J and the MMHD Study Group (1994). Recruitment sampling strategy and power analysis in the MMDH Study [Abstract]. Controlled Clinical Trials, 15, 33S.
  94. Schulman G, Gotch FA, Greene T, Keshaviah P, Massry SG, Meyer KB and the MMHD Study Group (1994). Variability of whole body urea transfer coefficient (Kc) in the Mortality and Morbidity in Hemodialysis Pilot Study [Abstract]. Journal of the American Society of Nephrology, 5, 528.
  95. Greene T, Beck G, Gassman J, Paranandi L, Schluchter M, Wang S, and the MDRD Study Group (1994). Considering changing the primary outcome of a clinical trial after examining the data: The Modification of Diet in Renal Disease (MDRD) Study [Abstract]. Controlled Clinical Trials, 15, 57S.
  96. Kusek JW, Agodoa L, Greene T, Jones C (1993). Modification of Diet in Renal Disease (MDRD) Study Group.Comparison of decline of GFR in Blacks versus Non-Blacks in the MDRD Study [Abstract]. Journal of the American Society of Nephrology, 4, 253.
  97. Hunsicker LG, Adler S, Caggiula A, England B, Greene T, Kusek J, Rogers N, Teschan P (1993). Modification of Diet in Renal Disease (MDRD) Study Group. Relationship among baseline proteinuria (P), mean arterial blood pressure (MAP) during Follow-Up, and decline in glomerular filtration rate (ΔGFR) in the Modification of Diet in Renal Disease Study [Abstract]. Journal of the American Society of Nephrology, 4, 254.
  98. Levey AS, Bosch JP, Coggins CH, Greene T, Mitch WE, Schluchter MD (1993). Modification of Diet in Renal Disease (MDRD) Study Group. Effects of diet and blood pressure on creatinine clearance (CCR) and serum creatinine (PCR) in the MDRD Study [Abstract]. Journal of the American Society of Nephrology, 4, 253.
  99. Levey AS, Beck GJ, Caggiula AW, Greene T, Hunsicker LG, Kusek JW, Klahr S (1993). Modification of Diet in Renal Disease (MDRD) Study Group. A hypothesis for the results of the Modification of Diet in Renal Disease (MDRD) Study [Abstract]. Journal of the American Society of Nephrology, 4, 253.
  100. Peterson JC, Burkart J, Greene T, Hebert L, King A, Klahr S, Massry S, Seifter J (1993). Modification of Diet in Renal Disease (MDRD) Study Group. The effect of blood pressure control on progression of renal disease depends on level of proteinuria (P) at baseline evaluation [Abstract]. Journal of the American Society of Nephrology , 4, 254.

Other

  1. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA (2012 May). Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Pharmag (7(5), pp. 844-50). United States.